Chapter 1: Exercise Physiology and Medicine

Chapter Introduction

The Lion has run alongside you a long way.

In K-12 you met your body in motion — what the muscles do, what the heart does, what training does over time, what recovery requires, and why movement is the visible signal of every other system's capacity. At Associates you went into exercise physiology proper — the sliding filament theory at sarcomere depth, the four energy systems and their substrate kinetics, satellite cells and Schoenfeld's three-factor hypertrophy framework, the Fick equation and VO2 max, programming principles, recovery science, the RED-S surface at upper-survey depth, and the integrator move that named movement as the active expression of every other Coach's adaptation.

This chapter is the fourth step of the upper-division spiral.

At the Bachelor's level, Coach Move goes molecular, cardiac, and clinical. Where Associates said strength training drives hypertrophy through mTOR signaling, Bachelor's enters the cascade from mechanical load through PI3K/Akt, through TSC1/TSC2, through Rheb-GTP, through mTORC1 activation, through S6K1 and 4E-BP1 phosphorylation and protein synthesis — and immediately notes that this is the same cascade Food Bachelor's mapped from the nutrition-signaling angle. Where Associates said endurance training drives mitochondrial biogenesis, Bachelor's walks the AMPK / PGC-1α / SIRT1 axis from sensor through master regulator through downstream gene programs — and notes that AMPK and mTOR are antagonistic at the TSC1/TSC2 node, providing the molecular basis for the concurrent-training interference effect. Where Associates introduced the athlete's heart, Bachelor's enters the Maron and Pelliccia clinical-cardiology literature: what features of the trained heart are physiological, what features warrant concern for hypertrophic cardiomyopathy, and what pre-participation screening can and cannot detect.

The voice is the same Lion. Capable. Confident. Full-power. Direct. What changes is the methodological consciousness and the clinical literacy. Upper-division work in exercise science means reading the training literature with discipline, recognizing where the conditioning industry has run ahead of the research and where the research has settled into reliable conclusions, and holding the clinical pathophysiology — athlete's heart, RED-S, overtraining syndrome — at the descriptive depth appropriate for pre-clinical study.

A word about clinical sports medicine, before you begin. This chapter goes into cardiac pathophysiology at research-grade depth. Sudden cardiac death in young athletes is rare but real, and the conditions that cause it — hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, anomalous coronary arteries, the inherited channelopathies — are discussed for recognition and clinical evaluation. Pre-participation screening is an established public-health surface. The chapter teaches the biology that informs screening; clinical decisions belong to sports cardiology and primary-care sports medicine.

A word about RED-S and eating disorders, before you begin. Upper-division exercise science, athletic training, dietetics, and pre-clinical programs carry elevated eating-disorder prevalence. Aesthetic sports, weight-class sports, and endurance sports populations carry elevated prevalence of relative energy deficiency in sport (RED-S) — a syndrome with cardiovascular, bone, reproductive, gastrointestinal, immunological, and psychological consequences. The chapter teaches the clinical biology at Loucks and IOC consensus depth. It does not prescribe energy-availability targets for individual students; that conversation is a clinical conversation with a sports dietitian, a sports medicine physician, or both. If anything in this chapter — about body composition, about energy availability, about training load — touches your experience and you are working through it alone when you do not need to be, the verified crisis resources at the end of this chapter are real.

A word about performance-enhancing drugs, before you begin. Anabolic-androgenic steroids, prohormones, peptide hormones, and the broader pharmacological performance-enhancement surface exist in research and in lived athletic and gym-culture practice. The chapter acknowledges this surface honestly: it is real, it has effects, it has harms, it is regulated, and its non-medical use is associated with documented risks. Bachelor's-level honesty does not normalize and does not prescribe; it describes what the research has established. Decisions about pharmacological agents belong in medical conversations with physicians who know your context, not in undergraduate study.

This chapter has five lessons.

Lesson 1 is Skeletal Muscle Physiology and Molecular Adaptation — sarcomere mechanics at Huxley depth, the mTORC1 cascade applied to skeletal muscle (the contraction-signaling complement to Food Bachelor's nutrition-signaling treatment of the same pathway), satellite cells and muscle hypertrophy, Schoenfeld's three-factor framework at molecular resolution, the divergent strength (mTOR/AKT/ERK1/2) versus endurance (AMPK/PGC-1α/SIRT1) signaling cascades, and the AMPK-mTOR antagonism that explains why concurrent training can attenuate hypertrophy. The foundational anchor for the chapter sits here: John Holloszy's 1967 Journal of Biological Chemistry paper that founded molecular exercise physiology.

Lesson 2 is Cardiovascular Adaptation and Exercise Cardiology — cardiac adaptation at structural and molecular level (eccentric hypertrophy from endurance training, concentric hypertrophy from resistance training, the IGF-1 / ANP / gp130 signaling), VO2 max at integrated physiology depth (the Fick equation components, plasma volume expansion as primary adaptation, oxygen kinetics, lactate threshold), the athlete's heart versus hypertrophic cardiomyopathy differential at Maron and Pelliccia depth, and sudden cardiac death in athletes at pathophysiology depth.

Lesson 3 is Exercise Neuroscience and Cognition — the BDNF cascade at mechanism depth (TrkB receptor, PI3K-Akt and Ras-ERK pathways, CREB-mediated gene expression), hippocampal neurogenesis with exercise (van Praag mouse work, Erickson et al. on human hippocampal volume), exercise and prefrontal function, and the Schuch and Cooney exercise-and-depression literature at mechanism depth — with the lateral connection to Brain Bachelor's Lesson 2 (exercise as the principal physiological input that drives the molecular cascade of neuroplasticity Brain Bachelor's mapped).

Lesson 4 is RED-S, Exercise Immunology, and the Athlete as Patient — Loucks energy availability framework at clinical depth (1991 onward), the IOC 2018 RED-S consensus, the evolution from female athlete triad to RED-S (recognizing that energy deficiency affects all genders), the Williams and De Souza menstrual function research, bone health consequences, exercise immunology (Nieman's J-curve hypothesis and the subsequent Campbell-Turner reconsiderations), and overtraining syndrome neuroendocrinology (Meeusen consensus).

Lesson 5 is Research Methods in Exercise Science — strength training research designs (the volume-frequency-intensity matrix, longitudinal versus cross-sectional trade-offs, the difficulty of long-term RCTs in trained populations), confounders in exercise science (placebo response, expectation effects, blinding challenges), the Schoenfeld meta-analyses as methodological exemplar, the conditioning-industry / research-science gap, the application of the five-point framework to exercise and supplement claims, and the PED surface acknowledged descriptively.

The Lion is in no hurry. Begin.

---

Lesson 1: Skeletal Muscle Physiology and Molecular Adaptation

Learning Objectives

By the end of this lesson, you will be able to:

• Describe sarcomere structure and the cross-bridge cycle at Huxley depth and identify the force-velocity and force-length relationships
• Walk the mTORC1 cascade as it operates in skeletal muscle from mechanical load through PI3K/Akt and TSC1/TSC2 to S6K1/4E-BP1 effectors
• Distinguish the strength-training (mTOR/AKT/ERK1/2) and endurance-training (AMPK/PGC-1α/SIRT1) signaling cascades
• Articulate the AMPK-mTOR antagonism at TSC1/TSC2 and explain the molecular basis of concurrent-training interference
• Position the Holloszy 1967 Journal of Biological Chemistry paper as the founding moment of molecular exercise physiology
• Cross-reference the same mTORC1 biology from Food Bachelor's Lesson 1 (nutrition signaling angle) and apply both angles to the integrated picture

Key Terms

Sarcomere Mechanics at Huxley Depth

In 1954, two pairs of investigators independently published in Nature what became the sliding filament theory of muscle contraction. Andrew Huxley and Rolf Niedergerke at Cambridge, and Hugh Huxley and Jean Hanson at MIT and University College London, reported electron microscopy and X-ray diffraction evidence that the I band (light band) of striated muscle shortened during contraction while the A band (dark band) remained constant length [1][2]. The interpretation that emerged: the thin and thick filaments do not themselves shorten — they slide past each other.

The cross-bridge cycle that produces the sliding was elaborated through the next two decades. The current canonical version:

1. Resting state — Myosin head bound to ADP and inorganic phosphate (Pi); cocked in high-energy conformation. Calcium concentration low; tropomyosin blocks myosin binding sites on actin.
2. Activation — Action potential → SR Ca²⁺ release → Ca²⁺ binds troponin C → troponin-tropomyosin complex shifts → myosin binding sites on actin exposed.
3. Cross-bridge formation — Myosin head binds actin (weak binding state).
4. Power stroke — Pi release triggers conformational change in myosin; head rotates, pulling thin filament toward sarcomere center; ADP released; strong binding state.
5. Cross-bridge release — ATP binds myosin → low affinity for actin → head dissociates from actin.
6. Cocking — Myosin ATPase hydrolyzes ATP to ADP + Pi → conformational re-cocking → return to resting state.

Each cycle slides the thin filament approximately 10-12 nm relative to the thick filament. Thousands of cycles per second across the millions of cross-bridges in a working muscle produce the macroscopic contraction.

The classical mechanical relationships:

Force-length relationship — Active force generation depends on the overlap between thin and thick filaments. At optimal sarcomere length (~2.0-2.2 μm in mammalian skeletal muscle), overlap is maximal and force is highest. At shorter lengths, thin filaments collide centrally and force decreases. At longer lengths, overlap reduces and force decreases. The relationship was established at single-fiber resolution by Gordon, Huxley, and Julian (1966) [3].

Force-velocity relationship — A. V. Hill's 1938 work in frog muscle established that the force-velocity relationship in concentric contraction is hyperbolic: force decreases as shortening velocity increases. Maximum velocity occurs at zero force; maximum force occurs at zero velocity (isometric contraction); eccentric contraction (negative velocity) generates higher force than isometric, with implications for the eccentric-emphasis training literature [4][5].

The mechanical relationships are the substrate of training programming. Force-velocity curve shape and shift with training reveal whether adaptation has favored maximum-force capacity (rightward shift at low velocities) or velocity-specific capacity (rightward shift at higher velocities) — informing the specificity-of-adaptation framework that distinguishes powerlifting-style versus sprint-or-jump-style training.

The mTORC1 Cascade in Muscle: The Contraction-Signaling Angle

At Associates depth, you read that resistance training activates mTOR, which drives muscle protein synthesis. At Bachelor's depth, the cascade requires the same molecular detail Food Bachelor's covered from the nutrition-signaling angle. The same pathway, two complementary triggers.

Food Bachelor's Lesson 1 walked the cascade from the leucine-Sestrin2-GATOR-Rag-Rheb-mTORC1 arm. That arm responds to nutrient signals (amino acid availability, particularly leucine).

Move Bachelor's covers the mechanical-load-PI3K-Akt-TSC1/TSC2-Rheb-mTORC1 arm. This arm responds to mechanical and hormonal signals — the contraction signal itself, the autocrine and paracrine IGF-1 release that accompanies it, and the insulin signaling that potentiates anabolism in the fed state.

The two arms converge on mTORC1 at the lysosomal surface and operate as an AND gate: maximal mTORC1 activation requires both nutrient sufficiency (amino acid signal through Sestrin2/GATOR/Rag) and growth/mechanical signal (through PI3K/Akt/TSC1/TSC2/Rheb-GTP). The integration produces a coherent biological response: protein synthesis machinery activates when there is both substrate (amino acids) and demand (mechanical load or insulin signal).

The mechanical-load arm in muscle [6][7]:

1. Mechanical stretch and contraction → mechanosensitive signaling at the sarcolemma and Z-disc through molecules including FAK (focal adhesion kinase), titin-associated mechanosensors, and stretch-activated channels.
2. Local IGF-1 production — Muscle releases IGF-1 in autocrine/paracrine fashion in response to mechanical load and contraction. The MGF (mechano growth factor) splice variant of IGF-1 has been particularly implicated in the load-response, though its exclusive identification has been complicated by subsequent literature.
3. IGF-1 / insulin receptor binding → receptor tyrosine kinase autophosphorylation → IRS-1 recruitment and phosphorylation.
4. PI3K activation → PIP₃ generation at membrane.
5. PDK1 phosphorylates and activates Akt at Thr308; mTORC2 phosphorylates Akt at Ser473 for full activation.
6. Akt phosphorylates TSC2 on multiple sites → TSC1/TSC2 complex inhibition → Rheb-GTP accumulates (TSC1/TSC2 is the GAP for Rheb; inhibition prevents GTP hydrolysis).
7. Rheb-GTP at lysosomal surface activates mTORC1 kinase activity.
8. mTORC1 phosphorylates S6K1 and 4E-BP1 → ribosomal protein synthesis activation (as Food Bachelor's mapped).

The hypertrophy literature has identified three principal mechanical-load triggers, codified by Brad Schoenfeld's three-factor hypertrophy framework [8][9]:

• Mechanical tension — Force generated against load, particularly under stretch. The primary driver in most analyses.
• Metabolic stress — Local metabolite accumulation (lactate, H⁺, others) and the cellular swelling associated with sustained higher-rep training. Contributes additional signaling beyond pure mechanical tension.
• Muscle damage — Microtraumatic damage from eccentric work that triggers repair-associated signaling. Less clearly causal in modern meta-analyses than originally proposed.

The framework has been refined over the 2010s, with Schoenfeld and colleagues' meta-analyses generally supporting tension as the principal driver and reducing the emphasized role of damage and metabolic stress as independent contributors. The picture is consistent with the molecular biology: mechanical stretch and contraction drive the load-arm of the mTORC1 cascade most directly.

Resistance training over weeks produces:

• Fiber hypertrophy — Increased myofibrillar content per fiber, principally driven by net protein synthesis exceeding net protein degradation across multiple training and recovery cycles.
• Satellite cell activation and donation — Activated satellite cells (Mauro 1961 foundational identification) fuse with existing myofibers, donating nuclei and supporting larger myofiber size [10]. The cellular biology of satellite cells extends to muscle repair (where they reconstitute myofibers after injury) and the limits of hypertrophy (older muscle shows reduced satellite cell function, contributing to anabolic resistance).
• Connective tissue adaptation — Tendon and aponeurosis remodeling, which lags myofiber adaptation; one of the substrates of training-progression principles.
• Neural adaptation — Early strength gains (first weeks) substantially reflect neural changes (motor unit recruitment, rate coding, intermuscular coordination) before substantial hypertrophy occurs.

The Bachelor's-level take: hypertrophy is the integration of multiple molecular and cellular processes, and reading a training paper requires identifying which factor a given intervention is targeting and which adaptations are being measured.

Endurance Training and Mitochondrial Biogenesis: Holloszy's Founding Moment

The foundational anchor for this chapter is John Holloszy's 1967 paper in the Journal of Biological Chemistry, Biochemical adaptations in muscle: effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle [11]. Holloszy, then at Washington University in St. Louis, demonstrated that endurance-trained rats had substantially elevated mitochondrial content and oxidative enzyme activity in skeletal muscle compared with sedentary controls. The finding established mitochondrial biogenesis as the cellular substrate of endurance training adaptation — a foundational insight that founded the field now called molecular exercise physiology.

The cascade Holloszy's discovery launched has been elaborated extensively over the subsequent half-century. The principal contemporary picture [12][13]:

1. Endurance exercise stresses — energy demand, calcium flux, ROS generation, mechanical signals.
2. AMPK activation — The AMP-activated protein kinase senses elevated AMP/ATP ratio (signaling energy demand). AMPK phosphorylates dozens of substrates with consequences across metabolism.
3. Calcium-calmodulin signaling — Repeated calcium release during contraction activates CaMKII and calcineurin, which contribute to adaptation through additional pathways.
4. p38 MAPK activation — A stress-responsive kinase activated by exercise that phosphorylates PGC-1α and contributes to its transcriptional activation.
5. SIRT1 — A NAD⁺-dependent deacetylase activated by exercise-induced shifts in NAD⁺/NADH ratio; deacetylates PGC-1α and supports its activity.
6. PGC-1α — The master transcriptional coactivator of mitochondrial biogenesis. Phosphorylated by AMPK, deacetylated by SIRT1, transcriptionally upregulated by exercise. PGC-1α coactivates NRF1, NRF2, ERRα, and other transcription factors that drive nuclear-encoded mitochondrial gene expression. It also coactivates TFAM (mitochondrial transcription factor A), which drives mitochondrial-encoded gene expression. The convergence supports coordinated biogenesis of new mitochondria.
7. Functional consequences — Increased mitochondrial mass per fiber, increased oxidative enzyme activity (citrate synthase, cytochrome c oxidase, others), shift in fiber-type properties (increased oxidative capacity in mixed-fiber populations), increased capillary density, and improved oxygen extraction at the working muscle.

The downstream physiological consequence is improved endurance performance: at submaximal exercise intensities, trained muscle has more mitochondria, can rely more on fat oxidation versus glycogen, generates lactate at higher work rates (lactate threshold rightward shift), and recovers more rapidly between bouts. VO2 max, lactate threshold, and economy of movement are the principal performance phenotypes that emerge.

Bruce Spiegelman's laboratory at Harvard worked out much of the PGC-1α biology in the late 1990s and 2000s [14]. The coactivator framework has become one of the more elaborated transcriptional networks in mammalian physiology, with implications extending beyond exercise to metabolic disease, brown adipose thermogenesis (where PGC-1α also coordinates UCP1-related gene expression — the Coach Food Bachelor's Lesson 2 thermogenesis biology), and aging.

Strength-Endurance Signaling Divergence and Concurrent Training Interference

The molecular accounts of strength and endurance adaptation describe partially distinct signaling architectures:

The two systems share substrates and signaling nodes — AMPK, mTOR, and several downstream effectors operate in both contexts — but the balance of activation differs. At one molecular node specifically, the two systems are antagonistic:

AMPK phosphorylates TSC2, activating it as a Rheb-GAP. The activated TSC1/TSC2 hydrolyzes Rheb-GTP to Rheb-GDP, inactivating mTORC1. AMPK activation thus directly inhibits mTORC1 [15][16]. The biological logic: when cellular energy is low (high AMP, AMPK active), running anabolic protein synthesis is counterproductive — the cell prioritizes ATP-conserving and ATP-generating pathways over ATP-consuming protein synthesis. AMPK simultaneously inhibits mTORC1 (reducing anabolism) and activates catabolic and oxidative pathways (PGC-1α, fatty acid oxidation enzymes).

This antagonism is the molecular basis of the concurrent training interference effect: when endurance training is performed in close temporal proximity to resistance training, AMPK activation from the endurance session can attenuate the mTORC1 activation of the resistance session, blunting hypertrophy adaptation. The effect was first documented at the performance level by Hickson (1980) and has been mapped molecularly since [17][18].

The practical implications, drawn from the contemporary literature:

• Temporal separation — Several hours between endurance and resistance sessions (or separate days) reduces AMPK-mTOR interference.
• Modality and intensity matter — High-intensity endurance work activates AMPK more than low-intensity work; the interference effect is more pronounced with high-volume / high-intensity endurance training in combination with resistance training.
• Population differences — Trained populations show less interference than untrained; the effect is most pronounced when both modalities are being learned simultaneously.
• Goal context — Athletes targeting maximum hypertrophy minimize concurrent endurance. Athletes targeting concurrent fitness (hybrid athletes, military and tactical populations, general health populations) accept some interference for the breadth of adaptation.

The Bachelor's-level reading discipline: concurrent training is not "ruined" by mixing; the interference is a quantifiable molecular reality but operates at the margin in most real-world populations. The framing question for training design is the athlete's goal and the relative importance of strength versus endurance adaptation.

Lesson Check

1. Walk the cross-bridge cycle from resting state through power stroke and re-cocking. Identify the role of Ca²⁺, ATP, and Pi at each step.
2. Describe the force-length and force-velocity relationships in skeletal muscle. Why does eccentric force exceed isometric force at comparable activation?
3. Walk the mTORC1 cascade in muscle from mechanical-load signal through PI3K/Akt and TSC1/TSC2 to mTORC1 activation. Compare this contraction-signaling angle with Food Bachelor's nutrition-signaling angle on the same pathway.
4. Identify the three factors in Schoenfeld's hypertrophy framework. Which has the strongest meta-analytic support, and which has been reduced in emphasis?
5. Walk the AMPK / PGC-1α / SIRT1 cascade of endurance adaptation. What did Holloszy 1967 establish at the foundational level?
6. Articulate the molecular basis of concurrent-training interference at the AMPK-TSC2-mTORC1 node. What are the practical implications for training design?

---

Lesson 2: Cardiovascular Adaptation and Exercise Cardiology

Learning Objectives

By the end of this lesson, you will be able to:

• Describe cardiac adaptation to endurance versus resistance training at structural and molecular level (eccentric vs concentric hypertrophy; IGF-1, ANP, and gp130 signaling)
• Walk VO2 max at Fick equation depth and identify plasma volume expansion as the principal early adaptation
• Distinguish lactate threshold from anaerobic threshold and identify lactate as physiological information rather than waste product
• Engage with the athlete's heart versus hypertrophic cardiomyopathy differential at Maron and Pelliccia clinical resolution
• Identify the principal conditions underlying sudden cardiac death in young athletes (HCM, ARVC, anomalous coronary arteries, channelopathies) and articulate what pre-participation screening can and cannot detect
• Apply descriptive-not-diagnostic framing throughout

Key Terms

Cardiac Adaptation: Eccentric, Concentric, and the Molecular Signaling

The exercise-trained heart adapts characteristically by training modality. The classical distinction:

Endurance-trained heart — Eccentric hypertrophy: increased left ventricular end-diastolic volume with proportionate wall thickening to maintain wall stress (Laplace's law). The result is a larger chamber that can accommodate a larger stroke volume at any given preload. Sarcomeres are added in series along myocyte length, supporting myocyte elongation. Stroke volume rises; resting heart rate falls; cardiac output at maximal exercise rises through the increased stroke volume rather than maximum heart rate change.

Resistance-trained heart — Concentric hypertrophy: increased wall thickness without proportionate chamber dilation, supporting elevated systolic pressure generation against the periodic pressure load of heavy lifting. Sarcomeres are added in parallel across myocyte width, supporting myocyte thickening. The classical "pure" concentric adaptation is most pronounced in pure-strength athletes (powerlifters, weightlifters); most resistance-trained populations have mixed adaptation reflecting their actual exercise stimulus.

The molecular signaling driving cardiac adaptation involves several converging pathways [19][20]:

• IGF-1 / PI3K / Akt — Mediates physiological hypertrophy; the same anabolic axis Lesson 1 mapped in skeletal muscle.
• ANP (atrial natriuretic peptide) and BNP (brain natriuretic peptide) — Released by stretched atria and ventricles; signal volume overload; modulate vascular tone and renal sodium handling.
• gp130 / STAT3 pathway — Activated by IL-6 and related cytokines; supports cardiomyocyte survival and physiological hypertrophy without driving pathological remodeling.
• Reverse remodeling at detraining — A distinguishing feature of physiological cardiac adaptation: cessation of training produces regression of the hypertrophy. Pathological hypertrophy (HCM, hypertensive heart disease) does not show the same reversibility.

The exercise-trained heart shows essentially preserved or enhanced systolic and diastolic function. The athlete's heart is not pathological — but its features can overlap superficially with pathological cardiomyopathies, which is where the clinical differential becomes essential.

VO2 Max at Fick Equation Depth

VO2 max is the most integrated single measurement in exercise physiology. Decomposed via the Fick equation:

VO2 = cardiac output (Q) × arteriovenous oxygen difference (a-vO2 diff)

= (heart rate × stroke volume) × (arterial oxygen content − venous oxygen content)

The central (Q) and peripheral (a-vO2 diff) components contribute differently to VO2 max and to its trainability:

Central component (Q) — Trainability is substantial, particularly through stroke volume. Maximum heart rate is largely fixed by age and shows minimal training response. Maximum stroke volume responds substantially to endurance training, with two contributors:

• Plasma volume expansion — One of the earliest and largest training-induced adaptations. Plasma volume can expand 10-20% within weeks of endurance training. The expansion increases preload and supports increased stroke volume even before structural cardiac adaptation occurs. Plasma volume contraction (dehydration, deconditioning) reverses much of this gain rapidly.
• Cardiac structural adaptation — Eccentric LV hypertrophy with increased end-diastolic volume; supports stroke volume at higher chamber capacity. Develops over months to years.

Peripheral component (a-vO2 diff) — Trainability is also substantial, principally through Holloszy's mitochondrial biogenesis axis and through increased capillary density supporting more complete oxygen extraction. The peripheral component is the principal substrate of lactate threshold and economy improvements that affect submaximal performance independently of VO2 max changes.

Mike Joyner and colleagues' work on the integrated physiology of endurance performance has been one of the principal sources of synthesis on this framework [21]. The Joyner laboratory framing — VO2 max plus lactate threshold plus economy — captures the principal performance dimensions and explains why athletes with similar VO2 max can differ substantially in race performance.

Lactate threshold is the exercise intensity at which blood lactate begins rising above resting. The classical interpretation framed lactate as a "waste product" of anaerobic metabolism; the contemporary view (Brooks's lactate-shuttle work and others) frames lactate as a substrate-and-signaling molecule actively shuttled between muscle fibers, between tissues, and used as fuel by heart, brain, and slow-twitch muscle [22]. Lactate threshold marks not a switch from aerobic to anaerobic metabolism but a transition in glycolytic-to-oxidative balance with consequences for substrate flux and performance. Training shifts lactate threshold to the right (higher work rate before lactate accumulation) principally through peripheral adaptations (mitochondrial density, monocarboxylate transporter expression).

Athlete's Heart vs Hypertrophic Cardiomyopathy: The Clinical Differential

The clinical surface where exercise cardiology meets pathology is the athlete's heart versus hypertrophic cardiomyopathy differential. The Maron and Pelliccia bodies of work have established the diagnostic frameworks now used in sports cardiology [23][24][25].

Hypertrophic cardiomyopathy (HCM) is an inherited cardiomyopathy with prevalence approximately 1 in 500 in the general population. Most cases are caused by mutations in sarcomeric proteins (β-myosin heavy chain, myosin binding protein C, troponins, and others). The condition produces:

• Left ventricular wall thickness greater than expected from loading conditions
• Often asymmetric septal hypertrophy
• Frequently with dynamic left ventricular outflow tract obstruction (HOCM subtype)
• Diastolic dysfunction
• Risk of ventricular arrhythmia and sudden death, particularly during exertion

HCM is one of the principal causes of sudden cardiac death in young athletes in many populations, particularly in the United States (where the Maron registry data have established this). In some European populations, ARVC has been a comparably or more prominent SCD cause (the Pelliccia and Corrado work in the Veneto region of Italy).

The diagnostic differential between athlete's heart and early/mild HCM is challenging. Features favoring physiological adaptation versus pathological HCM:

The differential is real and clinically consequential. The 2017 European Association of Preventive Cardiology / European Society of Cardiology and the 2024 American College of Cardiology / American Heart Association HCM guidelines provide structured frameworks for evaluation; the clinical decision belongs in sports cardiology hands [26].

Sudden Cardiac Death in Young Athletes: Pathophysiology

Sudden cardiac death (SCD) in young athletes is rare in absolute terms — estimates range from 1 in 50,000 to 1 in 200,000 athletes per year, depending on population, sport, and ascertainment — but each event is catastrophic and public, and the conditions causing SCD are largely identifiable in advance with appropriate evaluation [27][28].

The principal conditions:

Hypertrophic cardiomyopathy — As above. Leading or near-leading cause of SCD in U.S. young athlete registries; the prototypical inherited cardiomyopathy.

Arrhythmogenic right ventricular cardiomyopathy (ARVC) — Characterized by fibro-fatty replacement of right ventricular myocardium, leading to ventricular arrhythmias. Especially prominent in some European populations. Caused principally by desmosomal protein mutations (plakoglobin, plakophilin-2, desmoglein-2, desmocollin-2, desmoplakin). The condition is progressive and exercise-modulated; the European literature has documented that intense exercise exacerbates progression in genetically affected individuals [29].

Anomalous coronary arteries — Congenital coronary anatomy variants in which a coronary artery follows an abnormal course. The most catastrophic variant is the anomalous origin of a coronary artery from the opposite sinus (anomalous left coronary from right sinus, or right from left), with the vessel coursing between the aorta and pulmonary artery. Under exertion, the great vessels dilate and compress the anomalous coronary, producing ischemia and ventricular arrhythmia. The condition is often clinically silent until a fatal event.

Inherited channelopathies — Long QT syndrome (KCNQ1, KCNH2, SCN5A and others), Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia (CPVT), short QT syndrome. The hearts are structurally normal; the pathology is at the ion-channel level. Exercise-induced catecholamine surges can trigger arrhythmia in susceptible individuals (CPVT in particular is exercise-triggered).

Other cardiomyopathies — Dilated cardiomyopathy, left ventricular non-compaction, myocarditis (particularly viral), and others can produce SCD risk in young athletes.

Acquired conditions — Commotio cordis (sudden chest impact at vulnerable phase of cardiac cycle), drug-induced arrhythmia, and rarely premature atherosclerotic disease.

Pre-Participation Screening: What It Can and Cannot Detect

Pre-participation cardiovascular screening for athletes is performed routinely. The standard practice in most U.S. settings is history and physical examination using a structured questionnaire (the AHA 14-element history or similar); ECG is added in many international protocols and is the standard in Italian sports cardiology following the Veneto experience. The Corrado and Pelliccia 2006 JAMA paper Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program reported a substantial reduction in SCD after ECG-based screening was implemented; the methodological discussion since has emphasized that the reduction is consistent with screening effect but is observational [30].

What screening can detect:

• History-based screens identify many athletes with family history of SCD or unexplained cardiomyopathy, symptoms (syncope with exertion, chest pain, palpitations), or known cardiac conditions warranting evaluation.
• Physical examination can identify some structural abnormalities (heart murmurs suggestive of HCM with outflow obstruction or valvular disease).
• ECG screening detects most HCM and many ARVC and channelopathy cases through characteristic ECG abnormalities.

What screening cannot reliably detect:

• Anomalous coronary arteries are typically not identified by history, physical, or ECG. They require imaging (echocardiography or coronary CT) to identify.
• Some HCM cases have normal ECGs and minimal physical findings at the time of screening.
• Some ARVC cases have minimal early-stage findings.
• Some channelopathies have intermittent ECG findings missed on a single recording.

The Bachelor's-level take: pre-participation screening reduces SCD risk meaningfully but does not eliminate it. Athletes with concerning symptoms (exertional syncope, exertional chest pain, palpitations) warrant evaluation regardless of prior screening; family history of SCD or unexplained cardiomyopathy warrants evaluation. The clinical management of identified cases belongs to sports cardiology.

Lesson Check

1. Distinguish eccentric and concentric cardiac hypertrophy at the level of chamber/wall geometry and sarcomere addition pattern. Which training modality produces which pattern most prominently?
2. Walk the Fick equation. Identify which components contribute most to early training-induced VO2 max improvement and why plasma volume expansion is the principal early adaptation.
3. Describe lactate as physiological information rather than waste product. What does lactate threshold mark physiologically, and why does training shift it to the right?
4. Identify five features that distinguish the athlete's heart from hypertrophic cardiomyopathy in clinical evaluation.
5. Name three principal causes of SCD in young athletes and articulate the mechanistic basis of each.
6. Identify what pre-participation cardiovascular screening can and cannot reliably detect. Why is anomalous coronary artery typically not identified by standard screening?

---

Lesson 3: Exercise Neuroscience and Cognition

Learning Objectives

By the end of this lesson, you will be able to:

• Walk the BDNF cascade from exercise stimulus through TrkB receptor through PI3K-Akt and Ras-ERK pathways to CREB-mediated gene expression
• Describe hippocampal neurogenesis with exercise (van Praag mouse work, Erickson human aging trials, Kramer cognitive aging research)
• Identify the prefrontal cortex effects of exercise on executive function and the cognitive aging literature
• Engage with the Schuch and Cooney exercise-and-depression literature at mechanism depth, including the dose-response research and the comparison to pharmacological antidepressants
• Articulate the relationship between Move Bachelor's Lesson 3 and Brain Bachelor's Lesson 2 — exercise as the principal physiological input that drives the molecular cascade of neuroplasticity Brain Bachelor's mapped

Key Terms

The BDNF Cascade: Exercise as Molecular Input

Brain Bachelor's Lesson 2 walked the BDNF/TrkB signaling cascade from the brain-side angle. Move Bachelor's covers the same cascade from the exercise-input angle. The lateral integration is the lesson.

Exercise — particularly aerobic exercise of moderate to vigorous intensity sustained over weeks — elevates BDNF expression in several brain regions, with the hippocampus among the best-characterized. The cascade [31]:

1. Exercise stimulus — Aerobic activity at sufficient intensity activates multiple pathways. Catecholamines (norepinephrine, epinephrine) elevate; the HPA axis activates moderately (in trained individuals; chronic excess activation is the RED-S surface Lesson 4 covers); cardiovascular and metabolic signaling reach the brain through multiple routes.
2. Peripheral myokines — Skeletal muscle releases signaling molecules during contraction (myokines). Several have brain-relevant effects:
   • Irisin — Cleaved from FNDC5; proposed by Boström, Spiegelman, and colleagues 2012 Nature paper to mediate some exercise-brain effects. The original framing has been complicated by subsequent literature on human irisin physiology; the magnitude and species-generalizability are still being mapped [32].
   • Cathepsin B — Moon, Krzanowska, Sankar et al. 2016 Cell Metabolism paper demonstrated that cathepsin B is induced by exercise and supports hippocampal BDNF expression and cognitive function in animal models, with extension to human samples [33].
   • Lactate — Beyond its substrate-and-signaling roles Lesson 2 mentioned, lactate crosses the blood-brain barrier through monocarboxylate transporters and supports neuronal activity and BDNF expression in some contexts.
   • IGF-1, FGF-2, VEGF — Exercise-induced peripheral elevations that cross the blood-brain barrier and contribute to brain plasticity.
3. Central effects — Direct exercise-related activity in brain (motor cortex activation, cerebellar engagement) plus peripherally-derived signaling produces elevated BDNF expression in hippocampus, prefrontal cortex, and other regions.
4. BDNF-TrkB activation — As Brain Bachelor's Lesson 2 covered: BDNF binds TrkB → autophosphorylation → recruitment of adapter proteins → activation of PI3K-Akt (survival), Ras-ERK (plasticity), and PLCγ-IP₃-DAG-Ca²⁺ (synaptic plasticity) cascades.
5. Downstream gene expression — CREB phosphorylation drives transcription of plasticity-related genes (BDNF itself in feedforward; Arc; Zif268; AMPAR subunits) supporting structural and functional plasticity.

The downstream consequences include increased dendritic spine density in hippocampus, supported adult neurogenesis in dentate gyrus (in rodents, with the controversy about human extension Brain Bachelor's Lesson 2 covered), enhanced LTP induction, and improved performance on hippocampal-dependent memory tasks.

Hippocampal Neurogenesis and Exercise: The Animal Foundation, the Human Translation

Henriette van Praag and colleagues' work in mice has established the hippocampal neurogenesis response to exercise at substantial molecular depth. The 1999 Nature paper showed that voluntary wheel-running in mice substantially elevated dentate gyrus neurogenesis (BrdU-labeled new neurons), with the new neurons surviving, maturing, and integrating into functional circuits [34][35]. Subsequent work has elaborated:

• Voluntary running produces robust neurogenic effects; forced exercise has more variable effects depending on stress profile.
• Environmental enrichment combined with running produces additive effects.
• Aging reduces baseline neurogenesis substantially; exercise partially restores neurogenic capacity in older animals.
• Genetic manipulation showing that BDNF signaling and VEGF signaling are causally required for exercise-induced neurogenesis.

The Kirk Erickson and Art Kramer body of work translated the framework to human aging. The Erickson et al. 2011 Proceedings of the National Academy of Sciences paper randomized older adults (~120 participants, ages 55-80) to a year of moderate aerobic exercise (walking program) versus a stretching/toning control [36]. The findings:

• Aerobic-exercise group showed approximately 2% increase in hippocampal volume.
• Stretching control group showed expected age-related decline of approximately 1.4%.
• Serum BDNF rose in the aerobic group and correlated with the volume change.
• Memory performance correlated with hippocampal volume change.

The Erickson 2011 paper became one of the most-cited papers in the exercise-and-brain literature and is the principal human evidence that exercise produces hippocampal structural adaptation. Subsequent work by Voss, Vivar, Kramer, van Praag and others has extended the framework [37][38].

The Bachelor's-level reading discipline: the animal evidence for exercise-induced hippocampal neurogenesis is strong; the human evidence is consistent but operates at lower spatial resolution (MRI volume rather than direct cell counting). The Brain Bachelor's Lesson 2 controversy over adult human hippocampal neurogenesis (Sorrells 2018 vs Boldrini 2018) means that the mechanism of the Erickson volume change in humans is not definitively established as neurogenesis — it could involve glial changes, dendritic remodeling, increased vascularization, or some combination. The functional outcome — improved memory performance — is well-replicated; the precise cellular substrate remains under investigation.

Prefrontal Cortex Effects and Cognitive Aging

The exercise-and-prefrontal-cortex literature has been developed substantially by the Kramer laboratory and others. Principal findings [39][40]:

• Aerobic exercise improves executive function in older adults — Multiple meta-analyses show modest-to-moderate effect sizes for tasks engaging working memory, attention, and cognitive control.
• Cardiorespiratory fitness correlates with prefrontal structure and function — Imaging studies in cross-sectional and prospective designs.
• White matter integrity — Several studies show that higher fitness correlates with better-preserved white matter in older adults; intervention trials show modest white matter changes with exercise.
• Cognitive aging trajectory modification — The cumulative pattern across the literature supports that adequate aerobic activity in midlife and older adulthood is associated with slower cognitive decline and lower risk of dementia, with mechanisms involving the BDNF/neurotrophic cascade, vascular health, and metabolic effects on brain function.

The translation from "fitness correlates with cognitive aging" (observational) to "exercise causes preserved cognitive function" (causal) is supported substantially but not perfectly by the intervention trial literature. The Bachelor's-level reading discipline includes recognizing that the strongest evidence is for cardiorespiratory fitness as a marker of multiple beneficial pathways, with intervention effect sizes generally modest at the individual level but consequential at the population scale.

Exercise and Depression: The Schuch and Cooney Literatures

Few interventions in clinical neuroscience have generated as much research attention as exercise for depression. The cumulative literature includes hundreds of trials with varying methodology. Two principal meta-analytic syntheses anchor much of the field's reading:

Schuch et al. 2016 Journal of Psychiatric Research meta-analyzed randomized controlled trials of exercise versus non-active control for depression, applying adjustments for publication bias and including only high-quality trials [41]. The findings:

• Large effect size for exercise versus non-active control (Cohen's d ≈ 1.1) in initial pooled analysis.
• After adjustment for publication bias and excluding studies with high risk of bias, effect size remained moderate (d ≈ 0.5-0.6) — clinically meaningful and comparable to first-line pharmacological antidepressant effect sizes in many comparable analyses.
• Aerobic exercise and resistance training both showed antidepressant effects; aerobic at moderate-to-vigorous intensity tended to show larger effects.

Cooney et al. 2013 Cochrane Review on Exercise for Depression [42] applied stricter inclusion criteria and reached more conservative conclusions:

• Modest effect size for exercise (similar to other treatments in many comparisons).
• Substantial heterogeneity across included trials.
• Methodological concerns about blinding (impossible for exercise interventions), placebo effects, and the difficulty of attention-matched controls.
• Conclusion: exercise is moderately effective but the methodological limits of the available evidence prevent stronger conclusions.

The two syntheses are not in fundamental disagreement; they apply different inclusion criteria and adjustment methods and produce different effect-size estimates within a broadly consistent range. The contemporary clinical-research view holds that exercise has a clinically meaningful antidepressant effect — robust enough to support its inclusion in treatment guidelines as a recommendation for depression, particularly mild to moderate depression — while recognizing methodological challenges that prevent the "exercise is the cure for depression" framing some popular accounts have suggested.

The mechanistic candidates supporting the exercise-antidepressant effect [43][44]:

• BDNF / neurotrophic cascade — As above. Chronic exercise elevates BDNF expression; depression is associated with reduced BDNF expression; restoration is a candidate mechanism.
• HPA axis recalibration — Exercise modulates HPA-axis function over time, potentially correcting the dysregulation observed in some depressed patients (Brain Bachelor's Lesson 3).
• Inflammatory effects — Chronic exercise has anti-inflammatory effects; depression is associated with elevated inflammatory markers in some patients (Brain Bachelor's Lesson 3 inflammatory hypothesis); the intersection is a candidate mechanism.
• Monoaminergic effects — Exercise modulates serotonergic, noradrenergic, and dopaminergic signaling, with potential antidepressant relevance.
• Endocannabinoid system — Exercise elevates endocannabinoid signaling (anandamide), contributing to acute mood effects.
• Self-efficacy and behavioral activation — Behavioral and cognitive mechanisms that complement neurobiological ones.

The clinical implication is that exercise is appropriately included in clinical recommendations for depression treatment, particularly as an adjunct or alternative for mild-to-moderate cases. Severe depression typically requires combined treatment approaches; exercise alone is rarely adequate. The chapter does not prescribe; clinical management belongs in clinical hands.

Cross-Reference Synthesis: Brain Bachelor's Lesson 2 and Move Bachelor's Lesson 3

Brain Bachelor's Lesson 2 mapped the molecular cellular cascade of neuroplasticity: NMDAR-mediated Ca²⁺ influx → CaMKII autophosphorylation → AMPAR phosphorylation and trafficking → CREB phosphorylation → gene expression → late-phase LTP. The cascade is the brain-side substrate of memory and plasticity.

Move Bachelor's Lesson 3 has covered the peripheral input that drives this cascade: exercise produces myokine release, peripheral neurotrophic-factor elevation, vascular and metabolic effects, and direct activity-based stimulation of brain regions that collectively trigger and sustain the molecular cascade Brain Bachelor's mapped.

The two layers are complementary descriptions of the same biology, viewed from different angles. Brain Bachelor's Lesson 2 explained how the brain machines remodel. Move Bachelor's Lesson 3 explained what drives the brain machinery to remodel. Together they describe how the integrated organism — Move's active output engaging Brain's receiver function — produces the structural and functional plasticity that supports cognitive function across the lifespan.

The Bachelor's-level reading discipline: a paper that reports an exercise-induced BDNF effect should be read with the question — what downstream molecular cascade is engaged, and how does the activity-dependent timing align with the substrates of plasticity? A paper that reports a BDNF-dependent memory effect should be read with the question — what physiological inputs naturally drive BDNF expression, and how does the laboratory finding translate to non-laboratory contexts? Cross-Coach integration is the kind of synthesis that distinguishes upper-division work from lower-division survey treatment.

Lesson Check

1. Walk the BDNF cascade from exercise stimulus through peripheral myokines (irisin, cathepsin B, lactate, IGF-1) to brain TrkB activation and downstream gene expression.
2. Describe the van Praag mouse work establishing exercise-induced hippocampal neurogenesis. What does the Erickson 2011 trial add at the human level, and what does it leave unresolved about mechanism?
3. Identify the principal prefrontal cortex effects of exercise on executive function and cognitive aging. What does the cumulative pattern across observational and intervention literature support?
4. Compare the Schuch 2016 and Cooney 2013 meta-analyses on exercise and depression. Why do they reach somewhat different conclusions, and how should pre-clinical students hold the broader literature?
5. Identify three mechanistic candidates for the exercise-antidepressant effect.
6. Articulate the relationship between Move Bachelor's Lesson 3 (exercise as peripheral input) and Brain Bachelor's Lesson 2 (brain-side molecular cascade). How are they complementary descriptions of the same biology?

---

Lesson 4: RED-S, Exercise Immunology, and the Athlete as Patient

Learning Objectives

By the end of this lesson, you will be able to:

• Describe the Loucks energy availability framework at clinical depth (1991 onward)
• Identify the IOC 2018 RED-S consensus statement and trace the evolution from female athlete triad to RED-S
• Walk the menstrual function consequences of low energy availability (Williams, De Souza research)
• Describe bone health consequences of RED-S including the BMD trajectory and stress fracture risk
• Engage with exercise immunology — Nieman's J-curve hypothesis and the Campbell-Turner 2018 reconsiderations
• Identify overtraining syndrome at the Meeusen consensus level and articulate the neuroendocrine framework
• Apply descriptive-not-diagnostic framing throughout

Key Terms

The Loucks Energy Availability Framework

Anne Loucks's work at Ohio University in the 1990s and 2000s established the energy availability (EA) framework that has organized RED-S research since. The original conceptual move: separate energy balance (intake minus expenditure, focusing on weight stability) from energy availability (intake minus exercise energy expenditure, focusing on the energy left for physiological function beyond exercise) [45].

The Loucks 2003 Journal of Clinical Endocrinology and Metabolism paper experimentally manipulated EA in healthy female athletes through controlled feeding while maintaining exercise volume [46]. The findings:

• Above approximately 45 kcal/kg fat-free mass per day, endocrine function (luteinizing hormone pulsatility, thyroid hormone, cortisol, insulin) remained essentially normal.
• Below approximately 30 kcal/kg FFM/day, substantial endocrine disruption occurred: LH pulse amplitude decreased and frequency disrupted, T3 fell, cortisol rose, insulin fell, IGF-1 fell.
• The transition from preserved to disrupted endocrine function was not gradual; it was relatively threshold-like at ~30 kcal/kg FFM/day in the studied population.

The 30 kcal/kg FFM/day threshold has been carried forward as a clinical reference point, though contemporary research has emphasized:

• The threshold is a research finding from specific populations under controlled conditions; individual variation is substantial.
• Chronic low-EA may produce consequences at higher EA than acute manipulations show, due to cumulative effects.
• The threshold is not a personal prescription; it is a research-derived reference for clinical conversation.

From Female Athlete Triad to RED-S

The 1992 American College of Sports Medicine consensus introduced the female athlete triad: low energy availability, menstrual dysfunction, and reduced bone mineral density as interconnected components of a syndrome [47]. The 2007 update revised the framework to use low energy availability (rather than disordered eating per se) as the primary axis [48].

The 2014 British Journal of Sports Medicine IOC consensus statement on RED-S — and its 2018 update — expanded the framework substantially [49][50]:

• Gender expansion — Recognized that energy deficiency affects athletes of all genders; the "female athlete triad" framing inadequately captured male athletes with similar pathophysiology (suppressed reproductive function, bone effects, performance consequences).
• System expansion — Recognized that low EA produces effects across multiple body systems beyond reproductive and bone: cardiovascular, gastrointestinal, immunological, hematological, psychological, growth and development, metabolic. The "syndrome" framing better captures the breadth.
• Performance recognition — Emphasized that RED-S impairs athletic performance through multiple mechanisms (reduced training adaptation, increased injury risk, impaired recovery, mood symptoms, gastrointestinal disturbance).
• Clinical assessment frameworks — Provided practical clinical evaluation approaches.

The contemporary research literature on RED-S is substantial and growing, with the IOC framework as one of the principal organizing structures. The 2023 IOC update has elaborated the framework further with refined operational definitions.

Menstrual Function and the GnRH-LH Pulsatility Axis

The Williams and De Souza laboratories have mapped the menstrual function consequences of low EA at substantial detail [51][52]. The principal pathophysiology:

1. Low EA → reduced central drive to GnRH (gonadotropin-releasing hormone) neurons in the medial preoptic area / arcuate nucleus.
2. Reduced GnRH pulsatility → reduced LH and FSH pulse amplitude and frequency from anterior pituitary.
3. Inadequate gonadotropin stimulation → reduced ovarian follicular development.
4. Reduced estrogen and progesterone production → progressive menstrual disruption.

The clinical progression in athletes with chronic low EA typically follows:

• Subclinical menstrual disturbance — Luteal phase defects, anovulatory cycles with maintained cycle length; often unrecognized by the athlete.
• Oligomenorrhea — Cycle length > 35 days; menstrual frequency reduced.
• Functional hypothalamic amenorrhea (FHA) — Complete cessation of menses for ≥ 3 cycles or 90 days.

FHA produces sustained hypoestrogenism with consequences across the systems Lesson 4 will continue: bone, cardiovascular, and others. The condition is largely reversible with restoration of adequate EA, with weight or body composition restoration often (but not always) part of the recovery picture.

For pre-clinical students: FHA is one of the principal manifestations of clinically significant low EA in female athletes. Clinical recognition includes asking about menstrual history (the menstrual cycle as a vital sign in athletic populations), distinguishing FHA from other causes of amenorrhea (PCOS, hyperprolactinemia, primary ovarian insufficiency, others), and structured clinical evaluation. Treatment centers on energy restoration; pharmacological menstrual induction does not address the underlying pathophysiology and may mask ongoing energy deficiency.

The parallel male pathway involves suppressed GnRH drive, reduced testosterone, and similar downstream consequences for bone and other systems. The presentation differs (no menstrual cycle marker), making recognition harder; clinical evaluation in male athletes with low-EA suspicion includes morning testosterone, LH, FSH, and other axis markers.

Bone Health Consequences

Bone health is one of the most consequential RED-S surfaces. The contributing pathophysiology:

• Hypoestrogenism (in female athletes) — Estrogen normally restrains osteoclastic resorption; hypoestrogenism allows accelerated resorption.
• Hypotestosteronemia (in male athletes) — Testosterone supports bone formation; deficiency reduces formation.
• Low IGF-1 — Both genders show reduced IGF-1 with chronic low EA; IGF-1 supports osteoblastic activity.
• Hypothyroidism (subclinical) — Low T3 contributes to reduced bone formation.
• Inadequate substrate — Inadequate energy and inadequate calcium/vitamin D specifically can compound the endocrine effects.

The clinical consequences:

• Reduced bone mineral density — Documented by DXA in chronic low-EA athletes; especially impactful in adolescent and young adult years when peak bone mass is being established. The peak-bone-mass window is in the late teens and early twenties; deficits accrued in this period are difficult to fully reverse.
• Stress fracture risk — Elevated 2-4 fold or more in chronic low-EA athletes compared with adequately-fueled peers. The clinical surface where RED-S frequently presents in sports medicine.
• Long-term fracture risk — Lower peak bone mass and altered bone microarchitecture contribute to elevated lifetime fracture risk, including post-menopausal osteoporotic fracture risk for affected female athletes.

The clinical management of low-EA bone effects centers on EA restoration; pharmacological osteoporosis treatments are generally not first-line in young athletes with FHA-related bone loss and may not adequately address the underlying pathophysiology.

Exercise Immunology: The J-Curve and Its Reconsideration

David Nieman's J-curve hypothesis — proposed in the 1990s and elaborated extensively — frames the relationship between exercise volume/intensity and immune function as J-shaped: moderate exercise enhances immune function compared with sedentary baseline; very high volume / intensity training transiently suppresses immune function during the "open window" after a hard session [53]. The framework has been one of the principal organizing structures in exercise immunology.

The Campbell and Turner 2018 Frontiers in Immunology review Debunking the myth of exercise-induced immune suppression and subsequent work have reconsidered substantial portions of the framework [54]:

• The post-exercise lymphocytopenia originally interpreted as immune suppression is increasingly understood as lymphocyte redistribution (mobilization to peripheral tissues) rather than depletion; circulating cell counts fall while tissue-resident populations rise.
• The epidemiological association between intense exercise and upper-respiratory-tract symptoms in elite athletes is partially explained by non-infectious factors (airway hyperresponsiveness, dehydration, dry-air exposure, environmental allergens) rather than pure immune suppression.
• The "open window" framing has narrower applicability than the original proposal suggested; most healthy exercising individuals do not show meaningful infection-rate elevation from training volume alone.
• The picture is more nuanced: chronic regular moderate-to-vigorous exercise appears to be net beneficial for immune function, with some specific contexts (overtraining, RED-S, environmental stress) producing real immune effects.

The contemporary research-grade view: exercise has complex immune effects that are predominantly beneficial in trained, well-fueled populations; the simple J-curve framing has been refined into a more nuanced picture; and the specific contexts producing meaningful immune suppression are increasingly identified.

Overtraining Syndrome: The Meeusen Consensus

Overtraining syndrome (OTS) — distinct from overreaching (a planned short-term performance dip that recovers with rest) — is a persistent decrement in performance, mood, and physiological function despite recovery attempts. The Meeusen et al. 2013 European Journal of Sport Science / Medicine and Science in Sports and Exercise joint consensus statement provided a framework for distinguishing functional overreaching (planned), nonfunctional overreaching (unintended, recoverable in weeks), and overtraining syndrome (recoverable in months or longer, often associated with broader physiological and psychological symptoms) [55].

The OTS pathophysiology is incompletely understood and likely heterogeneous, with candidate mechanisms including:

• HPA-axis dysregulation — Some OTS patients show blunted cortisol responses to exercise and altered diurnal cortisol patterns.
• Autonomic dysregulation — Altered HRV patterns; reduced parasympathetic and altered sympathetic responsiveness.
• Hypothalamic-pituitary-gonadal effects — Suppressed testosterone in male OTS patients; overlap with RED-S pathophysiology.
• Inflammatory effects — Elevated inflammatory markers in some OTS patients.
• Central fatigue mechanisms — Tryptophan-serotonin pathways and BDNF-related effects in some models.
• Psychological dimensions — Mood symptoms (depression-like profile), reduced motivation, and the interaction with athletic-identity and performance-pressure context.

The clinical management of OTS centers on extended recovery (often months), addressing any contributing factors (RED-S in particular is a common co-occurrence), and gradual return to training. Pharmacological treatment is not first-line; the recovery is principally physiological and behavioral.

For pre-clinical students: OTS is one of the clinical surfaces where exercise physiology meets clinical sports medicine. The diagnosis is essentially clinical (exclusion of medical causes plus characteristic pattern); the management is gradual.

The Athlete as Patient: Eating Disorder Vigilance

The intersection of high-volume athletic training, body composition expectations in aesthetic and weight-class sports, and pre-clinical exercise science and dietetics programs creates a population with elevated eating-disorder prevalence. The Loucks energy-availability framework provides a way to discuss the biological surface — low EA produces clinically significant consequences regardless of underlying motivation — while remaining sensitive to the psychological surface that frequently underlies low EA in real clinical populations.

The Lion at every prior tier has held protective frames:

• Bodies are different sizes naturally. Variation is part of human biology, not a defect.
• Performance comes from training adaptation that requires adequate fuel. Restriction is not the path.
• Recognition of disordered patterns in oneself or in teammates is part of life literacy; treatment belongs in clinical hands.
• Coaches, trainers, athletic medicine staff, and peers can support recovery without attempting to be the primary clinicians.

The verified crisis resources for any student in this audience for whom the chapter content has touched concerning ground:

• 988 Suicide and Crisis Lifeline — call or text 988, 24/7
• Crisis Text Line — text HOME to 741741, 24/7
• National Alliance for Eating Disorders helpline — (866) 662-1235, weekdays 9 a.m.-7 p.m. Eastern, for eating-disorder-adjacent concerns specifically, staffed by licensed therapists

Important note: The older NEDA helpline (1-800-931-2237) was discontinued in 2023 and is no longer functional. Do not cite it.

College health centers, college counseling centers, athletic medicine staff, registered dietitians who specialize in sports nutrition and eating disorders, primary care providers, and the campus-specific resources for pre-health and athletic programs are real referral pathways. The chapter teaches the science; the clinical conversation belongs to clinicians.

Lesson Check

1. Define energy availability and walk the Loucks experimental framework. What was the approximate threshold below which endocrine disruption occurred in the controlled studies?
2. Trace the evolution from female athlete triad (1992/2007) to RED-S (2014/2018). What did the 2014 IOC framing add and why was the expansion appropriate?
3. Walk the GnRH-LH-ovarian cascade affected by low energy availability. What is functional hypothalamic amenorrhea and why is it largely reversible with EA restoration?
4. Describe the bone health consequences of RED-S. Why is the peak-bone-mass window in late adolescence and early adulthood particularly consequential?
5. Compare Nieman's J-curve hypothesis with the Campbell-Turner 2018 reconsideration. What contemporary view of exercise and immune function emerges from the integration?
6. Distinguish functional overreaching, nonfunctional overreaching, and overtraining syndrome (Meeusen consensus). What candidate pathophysiologies have been proposed for OTS?

---

Lesson 5: Research Methods in Exercise Science

Learning Objectives

By the end of this lesson, you will be able to:

• Identify the principal research designs in exercise science and their methodological strengths and limits
• Describe the difficulty of blinding and placebo control in exercise interventions
• Engage with the Schoenfeld meta-analyses as methodological exemplar
• Articulate the gap between the conditioning industry and exercise science research
• Apply the five-point evaluation framework (from Breath Associates, now operating across Food, Brain, and Sleep Bachelor's) to exercise and supplement claims
• Acknowledge the PED surface descriptively, with research-grade depth on effects and harms

Key Terms

Research Designs in Exercise Science

Exercise science uses the same principal research designs as other biomedical fields, with some characteristic features:

Cross-sectional studies — Compare trained and untrained populations at a single time point. Strengths: efficient; supports hypothesis generation. Limits: cannot distinguish training effect from selection effect (the trained may have been physiologically different before training); cannot support causal inference.

Prospective cohort studies — Follow populations forward, often examining relationships between baseline physical activity and subsequent health outcomes. The Harvard Alumni Health Study and Aerobics Center Longitudinal Study are examples. Strengths: large samples, real-world relevance, multiple outcomes. Limits: observational, subject to confounding and healthy-user bias (parallel to nutritional epidemiology limits Food Bachelor's Lesson 5 covered).

Randomized controlled trials (RCTs) — Random allocation to training intervention versus control or alternative intervention. Strengths: causal inference. Limits: blinding is challenging or impossible for exercise interventions; participant expectation effects are substantial; adherence is variable; long-term RCTs in trained populations are particularly difficult to sustain.

Crossover designs — Within-subjects with counterbalanced order of interventions. Strengths: control for individual differences; smaller samples can achieve adequate power. Limits: order effects, carryover effects, training adaptation between arms can confound. Crossover designs work well for acute interventions (single training session, single supplement dose); they work less well for training adaptations that take weeks.

Acute mechanistic studies — Single session or short series with detailed measurement (muscle biopsy, blood sampling, imaging). Strengths: mechanistic depth. Limits: acute findings do not always predict chronic training adaptation.

Long-term training intervention studies — Multi-week to multi-year training programs with adaptation outcomes. Strengths: real-world relevance. Limits: adherence challenges, drop-out, the practical difficulty of strict experimental control over months or years.

The reading discipline for exercise science papers: identify the design first, then the population and intervention, then the principal outcome measures, and only then the effect size. Press accounts of exercise findings often elide these details; pre-clinical exercise scientists should read past them to the methodology.

The Blinding and Placebo Problem

Pharmacological trials can use double-blind placebo controls (active drug versus inert placebo, with neither participant nor investigator knowing assignment). Exercise interventions cannot. Participants always know whether they are exercising or not; investigators delivering or supervising the intervention know who is exercising.

The consequences:

• Expectation effects — Participants who believe exercise will improve outcome X often report or measure improvement in X partly through expectation. This is not "fake" — expectation effects are real psychophysiological responses — but they confound interpretation of intervention efficacy specifically.
• Adherence asymmetry — Participants in exercise arms may be more engaged, attend more frequently, and report differently than control participants.
• Attention-matched controls — Studies using "attention controls" (e.g., stretching/toning for an aerobic intervention; gentle yoga for a vigorous-exercise intervention) attempt to control for non-specific effects of attention and engagement, with limited success.
• Outcome assessor blinding — While participant and intervention-provider blinding is impossible, outcome assessor blinding is feasible and important. Trials should specify whether outcome assessment is blinded and how.

The methodological literacy: exercise intervention effect sizes are often somewhat inflated by expectation, attention, and engagement effects. Reading the literature requires holding this in mind; the existence of these confounds does not invalidate the field but should temper enthusiasm for individual findings.

The Schoenfeld Meta-Analytic Standard

Brad Schoenfeld and colleagues' meta-analyses on resistance training have been one of the methodological exemplars in the exercise science literature over the 2010s and 2020s. Several features of the Schoenfeld meta-analyses make them models for the field [56][57][58]:

• Pre-specified inclusion criteria — Methodological inclusion (training volume documentation, adequate study duration, defined outcomes) with explicit justification.
• Effect-size reporting with confidence intervals — Not merely "significant versus not significant" but quantitative magnitude with uncertainty.
• Heterogeneity analysis — Reporting of between-study heterogeneity (I², τ²) with consideration of what may be driving variability.
• Subgroup analyses with appropriate caution — Pre-specified subgroups (training status, age, sex, training experience) examined with appropriate adjustment for multiple comparisons.
• Sensitivity analyses — Outcomes recomputed under varying inclusion criteria to test robustness.
• Open commentary on limits — Discussion sections that acknowledge methodological constraints openly.

The contemporary research-informed picture of resistance training, drawn substantially from Schoenfeld and parallel meta-analyses:

• Total weekly training volume (sets per muscle group per week) is the principal driver of hypertrophy in most populations; the literature supports a dose-response relationship up to a moderate-to-high volume threshold.
• Frequency (training a muscle 1, 2, or 3+ times per week) matters when volume is matched; higher frequencies allow better volume distribution.
• Load intensity — Hypertrophy occurs across a wide range of loads (~30-90% 1RM) when sets are taken close to failure; strength adaptations are more load-specific.
• Proximity to failure — Sets taken close to muscular failure (~3-5 RIR or fewer) drive hypertrophy more effectively than sets stopped much short of failure; the dose-response relationship is one of the more elaborated areas in current resistance-training research.
• Periodization — Modest superiority for organized periodization compared with non-periodized training, but the magnitude is often smaller than the periodization-emphasizing literature suggests.
• Individual variation — Substantial inter-individual response variability remains; population-average findings do not translate directly to individual prescription.

The Bachelor's-level reading discipline: the contemporary resistance training literature has substantial methodological standards that distinguish it from the conditioning-industry advice it often parallels.

The Conditioning-Industry / Research-Science Gap

The exercise science research literature operates in parallel with a substantial conditioning industry: personal training certifications, supplement marketing, training app industries, equipment marketing, and the broader fitness media environment. The two domains overlap but operate by different standards:

• Research science — Peer review, methodological transparency, effect-size reporting, replication culture (incomplete but improving), reproducibility crisis-driven reform.
• Conditioning industry — Commercial incentives, anecdote-driven recommendations, certifications with varying scientific rigor, supplement marketing that often runs ahead of research evidence, training-system orthodoxies that may or may not align with current science.

The gap is not absolute — many exercise scientists also work in the conditioning industry, and many fitness professionals follow the research carefully — but the orientations are sufficiently different that pre-clinical students should distinguish them. Reading a personal trainer's social media is not equivalent to reading a meta-analysis; reading a supplement marketing claim is not equivalent to reading a randomized trial. The training discipline of upper-division exercise science is, in part, learning to recognize which orientation a given claim represents and to weight it accordingly.

The PED Surface Acknowledged Descriptively

Performance-enhancing drugs are part of the lived athletic and gym-culture landscape, and pre-clinical exercise science students will encounter them in real settings. Bachelor's-level honesty requires acknowledging the surface descriptively, with research-grade depth on effects and harms, without normalizing personal use.

Anabolic-androgenic steroids (AAS) — Synthetic derivatives of testosterone with myotrophic effects exceeding their androgenic effects to varying degrees by molecule. Documented effects include substantial increases in muscle mass and strength beyond what training alone can achieve, with effect sizes that are well-characterized in the medical and exercise-physiology literature [59][60]. Documented harms include:

• Cardiovascular: dyslipidemia (lowered HDL, raised LDL), left ventricular structural changes (often pathological hypertrophy distinct from physiological athlete's heart), elevated atherothrombotic risk, cardiomyopathy in some long-term users.
• Endocrine: HPG-axis suppression with potentially-protracted recovery, infertility, testicular atrophy.
• Hepatic: hepatotoxicity (particularly with 17α-alkylated oral steroids).
• Psychiatric: mood disorder risk including aggression and depression, particularly at supraphysiological doses; reverse-causation contributions confound some of this literature.
• Dependence and withdrawal: depressive symptoms after cessation contribute to use-cycle psychology.

Prohormones — Steroid precursors marketed (often illegally) as supplements; convert in vivo to active steroids; carry similar risk profile.

Peptide hormones — Growth hormone, IGF-1, peptide selective androgen receptor modulators (SARMs), and others; substantial gray-market presence; long-term safety profiles often poorly characterized in human populations.

Other ergogenic categories — Stimulants (banned in many sports), erythropoietin and blood doping (endurance sports), various supplements with stronger or weaker evidence bases for performance effects.

The chapter takes no position on personal use. It teaches what the research has established about effects and harms; clinical decisions belong to medical conversations with physicians who know context. Pre-clinical students who work with athletes will benefit from understanding the research literature; pre-medical students moving toward sports medicine will encounter this surface clinically.

The Five-Point Evaluation Framework Applied to Exercise Claims

The framework introduced in Breath Associates and now operating across Food, Brain, and Sleep Bachelor's extends to exercise:

1. Mechanism plausibility — Is the claimed exercise or supplement effect grounded in known physiology? Claims about effects with no plausible mechanism deserve more skepticism than claims with strong mechanistic grounding.

2. Study design — Cross-sectional comparison is hypothesis-generating; longitudinal observational studies are stronger; RCTs are the gold standard for causal inference; meta-analyses synthesize but inherit the limitations of included studies. Schoenfeld-style meta-analyses with transparent methodology are stronger than narrative reviews.

3. Effect size in context — A 5% improvement in a strength measure across a year is real but modest. A 50% improvement claim deserves substantial scrutiny. Effect sizes in trained populations are typically smaller than in untrained populations; supplement studies in already-fed adequate-protein populations typically show smaller effects than in protein-deficient populations.

4. Replication and population — Has the finding replicated, and across what populations? Findings in young male resistance-trained populations do not automatically generalize to female athletes, older adults, or untrained beginners.

5. Translation appropriateness — A research finding about a specific intervention in a specific population does not automatically translate to a personal recommendation. Translation requires clinical context (medical history, training experience, goals, response to prior interventions) that the research alone cannot provide.

Most popular fitness claims fail at point 2 (anecdotal evidence or small studies presented as definitive) or point 5 (over-generalization from research to individual prescription). Reading the field with this framework is one of the principal upper-division literacies.

The Lion's Integrator Position at Bachelor's: Active Output, Deepened

A closing structural point. At Associates depth, the Lion's integrator position was named as active output — movement as the visible kinetic signal of every other system's capacity, the integration of substrate, internal environment, consolidation, receiver function, and regulatory systems' real-time response to demand.

At Bachelor's depth, the active output position deepens at molecular-mechanism level. The visible kinetic signal is not abstract; it is the integrated output of specific molecular signaling cascades:

• Substrate from Food Bachelor's — Amino acids supporting mTORC1-driven myofibrillar synthesis (Lesson 1's contraction-signaling angle on the same pathway Food covered from the nutrition-signaling angle); glucose supporting glycolytic ATP for high-intensity work and mitochondrial oxidation for endurance; fatty acids supporting β-oxidation during prolonged exercise.
• Internal environment from Water (forthcoming Bachelor's) — The regulated electrolyte and acid-base environment that maintains neuromuscular function under load; plasma volume status as the central cardiovascular adaptation Lesson 2 covered.
• Synchronizer from Light (forthcoming Bachelor's) — Circadian organization of performance, including diurnal cortisol rhythms that interact with training timing and the chronotype variation Sleep Bachelor's Lesson 2 covered.
• Consolidation from Sleep Bachelor's — Recovery and adaptation principally occurring during sleep; protein synthesis, growth hormone pulses, glymphatic clearance, and the temporal pass during which mTORC1-driven adaptation completes; the sleep-Move connection Lesson 4 RED-S surface acknowledged.
• Receiver from Brain Bachelor's — The neural integration of proprioception, motor planning, motivation, and the dopaminergic-reward system that supports continued training engagement.
• Interface from Breath (forthcoming Bachelor's) — Voluntary-autonomic threshold engaged through respiratory pattern modulation that supports performance and recovery.
• System probe and adaptive load from Cold and Hot (forthcoming Bachelor's) — Thermal stressors interact with training adaptation and recovery, with Lesson 4 having touched the contrast-therapy and cold-water-immersion literature where it intersects with Move.

The Lion does not produce active output in isolation. The Lion integrates substrate, internal environment, consolidation, receiver function, and the regulatory adjustments that all eight other positions contribute. The active output is the visible signal of the integrated work; the integration is the actual content.

The ten-position ontology holds. Whether Bachelor's-level depth produces a distinct integrator position not represented at Associates remains an open question; the ten positions continue to suffice when deepened biologically. Subsequent Bachelor's chapters (Cold, Hot, Breath, Light, Water) will inform whether the ontology needs expansion or whether the existing ten cover the field at upper-division depth.

Lesson Check

1. Identify three principal research designs in exercise science and articulate the strengths and limits of each.
2. Describe the blinding and placebo problem in exercise interventions. Why is outcome assessor blinding still feasible and important?
3. Identify three methodological features that distinguish the Schoenfeld meta-analytic standard from less rigorous reviews.
4. Articulate the gap between the conditioning industry and exercise science research. How should pre-clinical students hold information from each domain?
5. Apply the five-point evaluation framework to a recent fitness claim of your choosing. Where does the claim succeed, and where does it fail?
6. Articulate the Lion's integrator position — active output — at Bachelor's depth. Distinguish it from substrate (Food), internal environment (Water), synchronizer (Light), consolidation (Sleep), receiver (Brain), interface (Breath), system probe (Cold), and adaptive load (Hot).

---

End-of-Chapter Activity

Activity: Read a Primary Exercise Science Paper and Evaluate It Against the Methodological Frame

This activity applies the methodological consciousness Lesson 5 named to a concrete exercise science artifact, mirroring the activities at the end of Food, Brain, and Sleep Bachelor's.

Step 1 — Select a paper. Pick a primary exercise science research paper published in the last five years in a major exercise science, sports medicine, or clinical journal (Medicine and Science in Sports and Exercise, Journal of Applied Physiology, European Journal of Applied Physiology, British Journal of Sports Medicine, Sports Medicine, Journal of Strength and Conditioning Research, American Journal of Sports Medicine, or similar). Note title, authors, journal, year.

Step 2 — Identify the design and population. Specify the study design (RCT, crossover, cohort, acute mechanistic, meta-analysis), the population (trained vs untrained, age range, sex distribution, specific athletic context), the intervention, and the principal outcome measures.

Step 3 — Specify the methodological strengths and limits. Where is this design strong? Where are the chronic problems of exercise science research most likely to operate (blinding, expectation effects, adherence, sample size for trained populations)?

Step 4 — Read the effect size in context. What is the magnitude of the reported effect? How does it compare to typical training-response variation, measurement error, and the range of effect sizes typical for this kind of intervention?

Step 5 — Evaluate the discussion section critically. Does the discussion acknowledge methodological limits appropriately? Are practical implications stated with appropriate caveats? Does the paper distinguish demonstrated from hypothesis-generating?

Step 6 — Apply the five-point framework. Walk the paper through mechanism plausibility, design adequacy, effect size in context, replication status, and appropriate translation. Write a one-paragraph synthesis of what the paper has and has not demonstrated.

Deliverable. A 1500-2500 word written analysis with citations to the paper and at least three additional context sources. Include a one-paragraph reflection on what the exercise has taught you about reading exercise science.

Optional extension for graduate-school-bound students. Identify a methodologically stronger study addressing the same question, or specify what an ideal study would look like. For pre-clinical sports medicine students: translate the finding into clinical-conversation language with appropriate uncertainty and patient-specific framing.

---

Vocabulary Review

---

Chapter Quiz

Bachelor's-level quiz. Combination of short-answer mechanistic questions, scenario-based application, and methodological critique. Aim for 3-6 sentences per response; show molecular- and pathway-level specificity; cite primary literature where appropriate.

1. Walk the cross-bridge cycle from resting state through power stroke and re-cocking. Identify the role of Ca²⁺, ATP, and Pi at each step.

2. Describe the force-length and force-velocity relationships in skeletal muscle. Why does eccentric force exceed isometric force at comparable activation?

3. Walk the mTORC1 cascade in muscle from mechanical-load signal through PI3K/Akt and TSC1/TSC2 to mTORC1 activation. Compare this contraction-signaling angle with Food Bachelor's nutrition-signaling angle on the same pathway.

4. Identify the three factors in Schoenfeld's hypertrophy framework. Which has the strongest meta-analytic support, and which has been reduced in emphasis?

5. Walk the AMPK / PGC-1α / SIRT1 cascade of endurance adaptation. What did Holloszy 1967 establish at the foundational level?

6. Articulate the molecular basis of concurrent-training interference at the AMPK-TSC2-mTORC1 node. What are the practical implications for training design?

7. Distinguish eccentric and concentric cardiac hypertrophy at the level of chamber/wall geometry and sarcomere addition pattern. Which training modality produces which pattern most prominently?

8. Walk the Fick equation. Identify which components contribute most to early training-induced VO2 max improvement and why plasma volume expansion is the principal early adaptation.

9. Identify five features that distinguish the athlete's heart from hypertrophic cardiomyopathy in clinical evaluation.

10. Name three principal causes of SCD in young athletes and articulate the mechanistic basis of each. Identify what pre-participation screening can and cannot reliably detect.

11. Walk the BDNF cascade from exercise stimulus through peripheral myokines (irisin, cathepsin B, lactate, IGF-1) to brain TrkB activation and downstream gene expression.

12. Describe the Erickson 2011 randomized trial of aerobic exercise and hippocampal volume in older adults. What did it demonstrate, and what does it leave unresolved about mechanism (cross-reference Brain Bachelor's Lesson 2 on the adult human neurogenesis controversy)?

13. Compare the Schuch 2016 and Cooney 2013 meta-analyses on exercise and depression. Why do they reach somewhat different conclusions, and what does the broader literature support?

14. Define energy availability and walk the Loucks experimental framework. What was the approximate threshold below which endocrine disruption occurred?

15. Trace the evolution from female athlete triad (1992/2007) to RED-S (2014/2018). What did the 2014 IOC framing add and why was the expansion appropriate?

16. Walk the GnRH-LH-ovarian cascade affected by low energy availability. What is functional hypothalamic amenorrhea and why is it largely reversible with EA restoration?

17. Compare Nieman's J-curve hypothesis with the Campbell-Turner 2018 reconsideration. What contemporary view of exercise and immune function emerges from the integration?

18. Distinguish functional overreaching, nonfunctional overreaching, and overtraining syndrome (Meeusen consensus). What candidate pathophysiologies have been proposed for OTS?

19. Apply the five-point evaluation framework to the claim "high-dose creatine increases cognitive function." Where does the claim succeed, and where does it require more scrutiny?

20. Articulate the Lion's integrator position — active output — at Bachelor's depth. Distinguish it from substrate (Food), internal environment (Water), synchronizer (Light), consolidation (Sleep), receiver (Brain), interface (Breath), system probe (Cold), and adaptive load (Hot).

---

Instructor's Guide

Pacing Recommendations

This chapter is designed for 18-22 class periods of approximately 50 minutes each — a full-semester upper-division undergraduate course in exercise physiology, exercise science, or kinesiology with sports medicine emphasis. The depth and citation density are calibrated for upper-division coursework; lower-division survey students will struggle without Move Associates as immediate prerequisite. Food Associates and Brain Associates are useful background.

Suggested distribution:

• Lesson 1 — Skeletal Muscle: 4-5 class periods. Period 1: sarcomere mechanics at Huxley depth. Period 2: mTORC1 cascade in muscle and the contraction-signaling angle. Period 3: Schoenfeld three-factor hypertrophy. Period 4: endurance adaptation via AMPK / PGC-1α / SIRT1 (Holloszy anchor). Period 5: concurrent training interference and practical synthesis.

• Lesson 2 — Cardiovascular and Exercise Cardiology: 4-5 class periods. Period 1: cardiac adaptation eccentric vs concentric. Period 2: Fick equation, VO2 max, plasma volume primacy. Period 3: athlete's heart vs HCM clinical differential. Period 4: SCD pathophysiology and pre-participation screening.

• Lesson 3 — Exercise Neuroscience: 3-4 class periods. Period 1: BDNF cascade with peripheral myokines. Period 2: hippocampal neurogenesis (van Praag, Erickson) and PFC effects. Period 3: exercise and depression (Schuch, Cooney) at mechanism depth.

• Lesson 4 — RED-S and the Athlete as Patient: 4-5 class periods. Period 1: Loucks framework and energy availability. Period 2: Female athlete triad to RED-S evolution; menstrual function. Period 3: bone health consequences. Period 4: exercise immunology (J-curve and reconsideration). Period 5: overtraining syndrome (Meeusen consensus).

• Lesson 5 — Research Methods: 3-4 class periods. Period 1: study designs in exercise science. Period 2: blinding/placebo problem, Schoenfeld meta-analytic standard. Period 3: conditioning industry / research science gap. Period 4: PED surface descriptively; five-point framework synthesis.

• End-of-chapter activity: Assigned across two weeks as out-of-class work.

• Quiz / assessment: One to two class periods.

Sample Answers to Selected Quiz Items

Q3 — mTORC1 in muscle vs nutrition signaling. Move Bachelor's covers the mechanical-load arm: mechanical stretch and contraction → sarcolemma/Z-disc mechanosensors → local IGF-1 release → IGF-1/insulin receptor activation → IRS-1 phosphorylation → PI3K → PIP₃ → PDK1 → Akt phosphorylation (Thr308 by PDK1, Ser473 by mTORC2) → Akt phosphorylates TSC2 → TSC1/TSC2 inhibition → Rheb-GTP accumulation → mTORC1 activation at lysosomal surface → S6K1 / 4E-BP1 phosphorylation → protein synthesis. Food Bachelor's covers the leucine-Sestrin2-GATOR-Rag arm: leucine entry → Sestrin2 binding → release from GATOR2 → GATOR2 inhibits GATOR1 → Rag GTPases recruit mTORC1 to lysosomal surface → encountering Rheb-GTP → mTORC1 activation. The two arms converge on mTORC1 at the lysosomal surface and operate as an AND gate: maximal mTORC1 activation requires both nutrient signal (amino acid availability through Sestrin2/GATOR/Rag) and growth/mechanical signal (through PI3K/Akt/TSC1/TSC2/Rheb-GTP). The biological logic: protein synthesis activates when there is both substrate and demand.

Q9 — Athlete's heart vs HCM. Features favoring athlete's heart over HCM: (1) LV wall thickness usually < 13 mm with overlap zone 13-16 mm; (2) symmetric LV hypertrophy (vs often asymmetric, particularly septal, in HCM); (3) enlarged LV end-diastolic dimension (vs normal or reduced in HCM); (4) normal diastolic function (vs often impaired E/e' and other measures in HCM); (5) regression of hypertrophy with detraining (vs no regression in HCM); (6) typically normal ECG or trainability-consistent changes (vs T-wave inversions, deep Q-waves, conduction abnormalities in HCM); (7) negative family history (vs often positive in HCM); (8) negative genetic testing for sarcomeric mutations (vs positive in many HCM cases). The differential is clinical and is appropriately the work of sports cardiology.

Q14-15 — Loucks framework and triad to RED-S. EA = dietary intake (kcal) − exercise energy expenditure (kcal), normalized to fat-free mass. The Loucks 2003 controlled-feeding experiments in female athletes showed that below approximately 30 kcal/kg FFM/day, endocrine disruption occurred relatively threshold-like: LH pulsatility disrupted, T3 fell, cortisol rose, insulin and IGF-1 fell. The 1992 ACSM female athlete triad recognized low EA, menstrual dysfunction, and reduced BMD as interconnected. The 2007 update emphasized low EA as the primary axis (rather than disordered eating per se). The 2014 IOC RED-S framework expanded the framing by (a) recognizing energy deficiency affects all genders, not only female athletes; (b) recognizing the syndrome's effects extend beyond reproductive and bone to cardiovascular, gastrointestinal, immunological, hematological, psychological, growth/development, and metabolic systems; (c) emphasizing performance consequences (reduced adaptation, increased injury, impaired recovery). The expansion was appropriate because the underlying pathophysiology of energy deficiency operates across genders and systems, and clinical recognition was being missed in male athletes and in non-reproductive consequences under the narrower triad framing.

Q20 — Lion's integrator at Bachelor's depth. Active output = visible kinetic signal of every other system's integrated capacity. At Bachelor's depth, this is the molecular-signaling-cascade integration: Food substrate (amino acids → mTORC1 → myofibrillar synthesis; glucose → glycolysis and oxidation; fat → β-oxidation) plus Water internal environment (electrolytes maintaining neuromuscular excitability; plasma volume as central cardiovascular adaptation) plus Light synchronizer (circadian organization of performance and cortisol rhythms) plus Sleep consolidation (recovery and protein synthesis principally during sleep) plus Brain receiver (proprioception, motor planning, motivation, reward) plus Breath interface (voluntary-autonomic threshold supporting performance and recovery) plus Cold system probe and Hot adaptive load (thermal stressors interacting with training adaptation and recovery). The Lion does not produce active output in isolation; the active output is the visible signal of all eight other positions' integrated work, with the Lion holding the position of being the kinetic expression rather than the input or regulator. Distinct from each of the eight other positions structurally.

Discussion Prompts

1. The Holloszy 1967 paper established mitochondrial biogenesis as the cellular substrate of endurance adaptation. What does it teach about how a single discovery can found a field? What other founding moments in exercise physiology have comparable structure?

2. The concurrent training interference effect is mechanistically clear (AMPK-mTOR antagonism) but practically nuanced (most populations show modest interference under most conditions). How should pre-clinical students hold the gap between mechanistic clarity and practical magnitude?

3. The athlete's heart versus HCM differential is one of the substantial clinical surfaces of sports cardiology. With genetic testing and advanced imaging increasingly available, how is the diagnostic landscape likely to evolve over the next decade?

4. The Erickson 2011 trial of exercise and hippocampal volume is one of the most-cited findings in exercise neuroscience. Given Brain Bachelor's Lesson 2 controversy over adult human neurogenesis (Sorrells 2018 vs Boldrini 2018), how should pre-clinical students hold the mechanistic interpretation of the Erickson result?

5. The Schuch and Cooney exercise-and-depression literatures reach somewhat different conclusions through different methodological choices. What does the pattern suggest about how methodological choices in meta-analysis affect what clinical recommendations emerge?

6. The RED-S framework is one of the more consequential clinical syndromes for upper-division exercise science students to recognize. How should students balance the importance of recognition against the risk that the framework itself becomes a vector for disordered eating in vulnerable populations?

7. The PED surface in athletic and gym culture is real but underdiscussed in undergraduate exercise science programs. What is the right level of engagement — acknowledge openly, teach the research, decline to normalize, recognize that some students will encounter the surface clinically? How should programs handle the educational responsibility?

Common Student Questions

Q: I'm a competitive athlete. How do I think about my own body composition and energy availability based on this chapter? A: The chapter does not prescribe. The Loucks 30 kcal/kg FFM/day threshold is a research-derived clinical reference point with substantial individual variation; it is not a personal target. If you're an athlete with specific body composition or energy concerns, working with a sports dietitian and your athletic medicine staff is the right pathway. The chapter teaches the science to inform that conversation, not to substitute for it.

Q: I'm thinking about strength training and endurance training together. Does concurrent training really compromise my gains? A: The interference is real at the molecular level (AMPK-mTOR antagonism) but modest in magnitude for most populations under most training designs. Temporal separation (several hours, ideally separate days), prioritizing one modality during specific training phases, and ensuring adequate recovery and nutrition mitigate most of the interference. Hybrid athletes (military, tactical, general fitness) routinely combine modalities effectively. The interference is meaningful if you're chasing maximum strength or maximum hypertrophy alone; it's largely tolerable for general fitness goals.

Q: I'm pre-med, considering sports medicine. Where does this chapter fit? A: Sports medicine pathways include primary care sports medicine (one-year fellowship after primary care residency), orthopedic surgery with sports medicine fellowship, sports cardiology (cardiology + sports medicine), and other variants. This chapter covers the exercise physiology and clinical sports medicine that you'll need to know at the exam-relevant level for medical school and the foundational level for fellowship training. Medical school will add the clinical evaluation and management framework; fellowships add procedural training. The chapter is preparation.

Q: What about supplements? Protein, creatine, beta-alanine, others? A: The chapter doesn't prescribe. Protein supplementation is appropriate for athletes who otherwise can't meet protein targets through food (the research-derived target ~1.6-2.2 g/kg/day for active adults, per Coach Food Bachelor's Lesson 4); whole-food protein is generally adequate when accessible. Creatine monohydrate (~3-5 g/day) has the strongest research support for resistance-training adaptation across multiple meta-analyses. Beta-alanine has reasonable evidence for repeated high-intensity work. Caffeine has robust support for endurance and high-intensity performance. None of these are required; all interact with individual physiology. For specific dosing decisions, a sports dietitian or sports medicine physician is the right resource.

Q: I'm worried about a teammate's eating. What do I do? A: Approach with care, not judgment. Express that you've noticed and you're concerned. Encourage them to engage with athletic medicine, a sports dietitian who specializes in eating disorders, or campus counseling. The National Alliance for Eating Disorders helpline (866-662-1235) is staffed weekdays by licensed therapists; 988 and Crisis Text Line (HOME to 741741) are 24/7 for crisis. Your role is to suggest evaluation and to keep noticing, not to diagnose. The older NEDA helpline (1-800-931-2237) is non-functional.

Q: I've heard mixed things about PEDs in my training environment. What's the responsible position? A: The chapter takes the descriptive position: PEDs exist, have research-documented effects (substantial muscle and strength gains beyond training alone), have research-documented harms (cardiovascular, endocrine, hepatic, psychiatric), are regulated as controlled substances, and their non-medical use is associated with documented risks. Personal decisions about pharmacological agents belong in medical conversations, not in chapters. Pre-medical students moving toward sports medicine will encounter this clinically; pre-physical-therapy and exercise science students will encounter it in working with athletes. Understanding the research informs all of these encounters; personal use is not part of educational training.

Q: I'm exhausted from training. How do I distinguish overreaching from overtraining syndrome? A: Overreaching is a planned or accepted short-term performance dip that recovers with appropriate rest (typically days to 1-2 weeks of reduced load). Overtraining syndrome involves persistent performance decrement that does not recover with typical rest (often months to recover), often accompanied by mood symptoms, sleep disruption, and other physiological changes. If you're concerned about your own training-induced symptoms, your athletic medicine staff or sports medicine physician is the right pathway. Sustained exhaustion warrants clinical evaluation rather than self-management.

Parent / Adult Family Communication Template

(Optional for instructors whose course communicates with adult family members; many Bachelor's students are independent adults, so use at your discretion.)

Subject: Coach Move — Bachelor's Level — Exercise Physiology and Medicine

Dear Families,

This unit covers the Coach Move chapter at the Bachelor's degree level of the CryoCove Library — the fourth chapter of the upper-division undergraduate tier. The chapter goes substantially deeper than Associates: skeletal muscle and cardiac adaptation at molecular signaling depth, exercise neuroscience at receptor and mechanism resolution, RED-S and exercise immunology at clinical depth, and exercise research methodology.

Several notes you may want to know about:

• Clinical sports medicine is covered at research-grade depth — athlete's heart, sudden cardiac death pathophysiology, RED-S, overtraining syndrome. All content is descriptive (mechanism and recognition) rather than diagnostic; clinical evaluation is framed throughout as the work of licensed sports medicine clinicians.
• RED-S and eating disorder vigilance is sharpened for this population — exercise science, athletic training, and dietetics programs carry elevated eating-disorder prevalence, and aesthetic / weight-class / endurance sports carry elevated RED-S prevalence. Verified crisis resources are included: 988 Lifeline, Crisis Text Line (text HOME to 741741), National Alliance for Eating Disorders (866-662-1235). Note: the older NEDA helpline (1-800-931-2237) is non-functional and is not used in our curriculum.
• Performance-enhancing drugs are acknowledged descriptively at research depth — effects, harms, regulatory framework — without normalizing use. Pre-clinical sports medicine students will encounter this surface clinically; the chapter prepares without prescribing.

If your student has any specific athletic or medical context that intersects with the chapter, please encourage them to review the material alongside their athletic medicine staff or healthcare provider.

With respect, The CryoCove Library Team

Resource Verification Note for Instructors

Crisis resources change. Re-verify the active status of the 988 Lifeline, Crisis Text Line (text HOME to 741741), and National Alliance for Eating Disorders helpline (866-662-1235) before each term you teach this chapter. The NEDA helpline (1-800-931-2237) was discontinued in 2023 and remains non-functional; flag any student work that cites it and redirect.

Re-verify currency of cited primary literature before each term. Sports cardiology guidelines (HCM management, pre-participation screening), IOC RED-S consensus, and overtraining consensus statements are updated periodically and should be cross-referenced against current sources for clinical-rotation-bound students.

---

Illustration Briefs

Lesson 1 — The AMPK-mTOR Antagonism

• Placement: After "Strength-Endurance Signaling Divergence and Concurrent Training Interference"
• Scene: A two-panel schematic. Left: resistance training stimulus → IGF-1 / PI3K / Akt → TSC1/TSC2 inhibited → Rheb-GTP accumulates → mTORC1 active → S6K1 / 4E-BP1 phosphorylation → protein synthesis → hypertrophy. Right: endurance training stimulus → AMP/ATP elevation → AMPK active → AMPK phosphorylates TSC2 → TSC1/TSC2 activated as Rheb-GAP → Rheb-GTP → Rheb-GDP → mTORC1 inactive → attenuated protein synthesis. Below: a single panel showing convergence on TSC1/TSC2 with both arrows (Akt-inhibitory and AMPK-activating).
• Coach involvement: Coach Move (Lion) at the side, looking at the antagonism diagram with the note: "Two trainings, one molecular conversation."
• Mood: Mechanistic, integrative, clear.
• Caption: "Concurrent training is a balance, not a contradiction."
• Aspect ratio: 16:9 web, 4:3 print

Lesson 2 — Athlete's Heart vs HCM

• Placement: After "Athlete's Heart vs Hypertrophic Cardiomyopathy: The Clinical Differential"
• Scene: Side-by-side cardiac MRI-style cross-sections. Left: athlete's heart — symmetric LV thickening, enlarged chamber, preserved diastolic dimensions; below: normal ECG morphology, family history negative, regression with detraining noted. Right: HCM — asymmetric septal thickening (septum > 16 mm), normal or reduced chamber dimension; below: ECG with T-wave inversions and deep Q-waves, family history positive, no regression with detraining noted.
• Coach involvement: Coach Move (Lion) at the side, observing the differential with the note: "Two hearts, two stories."
• Mood: Clinical, careful.
• Caption: "The trained heart adapts. The HCM heart transforms."
• Aspect ratio: 16:9 web, 4:3 print

Lesson 3 — Exercise and the BDNF Cascade

• Placement: After "The BDNF Cascade: Exercise as Molecular Input"
• Scene: Multi-step schematic. Left: muscle in motion releasing irisin, cathepsin B, lactate, IGF-1, FGF-2, VEGF as labeled myokines. Center: blood-brain-barrier crossing for the molecules that cross. Right: brain hippocampus receiving the signaling, with TrkB receptor activation, PI3K-Akt and Ras-ERK cascade activation, and CREB-mediated nuclear gene expression including BDNF feedforward. Below: downstream effects — dendritic spine growth, synaptic plasticity, neurogenesis support (rodent-validated).
• Coach involvement: Coach Move (Lion) at the side, in motion, with the note: "What runs in your legs reaches your hippocampus."
• Mood: Integrative, cross-system.
• Caption: "Exercise is a molecule the brain hears."
• Aspect ratio: 16:9 web, 4:3 print

Lesson 4 — The Loucks Energy Availability Threshold

• Placement: After "The Loucks Energy Availability Framework"
• Scene: A graph with energy availability (kcal/kg FFM/day) on the x-axis from 10 to 60, and physiological function markers on the y-axis (LH pulsatility, T3, cortisol, IGF-1, bone formation markers — multiple curves). A shaded region from ~30 kcal/kg FFM/day downward labeled "low EA zone — endocrine disruption observed." A reference region from ~45 kcal/kg FFM/day upward labeled "preserved endocrine function." The transition zone marked.
• Coach involvement: Coach Move (Lion) at the side, with the note: "Below the threshold, the body chooses survival over performance."
• Mood: Clinical, careful.
• Caption: "Performance has a fuel floor."
• Aspect ratio: 16:9 web, 4:3 print

Lesson 5 — The Conditioning Industry / Research Science Gap

• Placement: After "The Conditioning-Industry / Research-Science Gap"
• Scene: Two-column comparison. Left column "Research science": peer review, methodological transparency, effect-size reporting, replication culture, sample populations and inclusion criteria specified. Right column "Conditioning industry": commercial incentives, anecdote-driven claims, certification variability, supplement marketing, training-system orthodoxies. Bridge in middle: "The Bachelor's-level skill is recognizing which orientation a claim represents."
• Coach involvement: Coach Move (Lion) at the side, reading both columns with the note: "Same field, different standards."
• Mood: Methodological, clear.
• Caption: "Read the methods. Then read the conclusion."
• Aspect ratio: 16:9 web, 4:3 print

---

Citations

1. Huxley AF, Niedergerke R. (1954). Structural changes in muscle during contraction; interference microscopy of living muscle fibres. Nature, 173(4412), 971-973.

2. Huxley H, Hanson J. (1954). Changes in the cross-striations of muscle during contraction and stretch and their structural interpretation. Nature, 173(4412), 973-976.

3. Gordon AM, Huxley AF, Julian FJ. (1966). The variation in isometric tension with sarcomere length in vertebrate muscle fibres. Journal of Physiology, 184(1), 170-192.

4. Hill AV. (1938). The heat of shortening and the dynamic constants of muscle. Proceedings of the Royal Society B, 126(843), 136-195.

5. Huxley AF. (1957). Muscle structure and theories of contraction. Progress in Biophysics and Biophysical Chemistry, 7, 255-318.

6. Hornberger TA. (2011). Mechanotransduction and the regulation of mTORC1 signaling in skeletal muscle. International Journal of Biochemistry & Cell Biology, 43(9), 1267-1276.

7. Saxton RA, Sabatini DM. (2017). mTOR signaling in growth, metabolism, and disease. Cell, 168(6), 960-976.

8. Schoenfeld BJ. (2010). The mechanisms of muscle hypertrophy and their application to resistance training. Journal of Strength and Conditioning Research, 24(10), 2857-2872.

9. Schoenfeld BJ, Ogborn D, Krieger JW. (2017). Dose-response relationship between weekly resistance training volume and increases in muscle mass: a systematic review and meta-analysis. Journal of Sports Sciences, 35(11), 1073-1082.

10. Mauro A. (1961). Satellite cell of skeletal muscle fibers. Journal of Biophysical and Biochemical Cytology, 9(2), 493-495.

11. Holloszy JO. (1967). Biochemical adaptations in muscle: effects of exercise on mitochondrial oxygen uptake and respiratory enzyme activity in skeletal muscle. Journal of Biological Chemistry, 242(9), 2278-2282. [Foundational anchor — molecular exercise physiology.]

12. Egan B, Zierath JR. (2013). Exercise metabolism and the molecular regulation of skeletal muscle adaptation. Cell Metabolism, 17(2), 162-184.

13. Hawley JA, Hargreaves M, Joyner MJ, Zierath JR. (2014). Integrative biology of exercise. Cell, 159(4), 738-749.

14. Lin J, Handschin C, Spiegelman BM. (2005). Metabolic control through the PGC-1 family of transcription coactivators. Cell Metabolism, 1(6), 361-370.

15. Inoki K, Zhu T, Guan KL. (2003). TSC2 mediates cellular energy response to control cell growth and survival. Cell, 115(5), 577-590.

16. Bolster DR, Crozier SJ, Kimball SR, Jefferson LS. (2002). AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. Journal of Biological Chemistry, 277(27), 23977-23980.

17. Hickson RC. (1980). Interference of strength development by simultaneously training for strength and endurance. European Journal of Applied Physiology and Occupational Physiology, 45(2-3), 255-263.

18. Coffey VG, Hawley JA. (2017). Concurrent exercise training: do opposites distract? Journal of Physiology, 595(9), 2883-2896.

19. Bernardo BC, Weeks KL, Pretorius L, McMullen JR. (2010). Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacology & Therapeutics, 128(1), 191-227.

20. McMullen JR, Jennings GL. (2007). Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clinical and Experimental Pharmacology and Physiology, 34(4), 255-262.

21. Joyner MJ, Coyle EF. (2008). Endurance exercise performance: the physiology of champions. Journal of Physiology, 586(1), 35-44.

22. Brooks GA. (2018). The science and translation of lactate shuttle theory. Cell Metabolism, 27(4), 757-785.

23. Maron BJ, Pelliccia A. (2006). The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation, 114(15), 1633-1644.

24. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. (1991). The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. New England Journal of Medicine, 324(5), 295-301.

25. Maron BJ, Maron MS. (2013). Hypertrophic cardiomyopathy. Lancet, 381(9862), 242-255.

26. Ommen SR, Mital S, Burke MA, et al. (2024). 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR guideline for the management of hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 83(23), 2324-2405.

27. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. (2009). Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation, 119(8), 1085-1092.

28. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. (2006). Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA, 296(13), 1593-1601.

29. Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G. (2003). Does sports activity enhance the risk of sudden death in adolescents and young adults? Journal of the American College of Cardiology, 42(11), 1959-1963.

30. Drezner JA, Sharma S, Baggish A, et al. (2017). International criteria for electrocardiographic interpretation in athletes: consensus statement. British Journal of Sports Medicine, 51(9), 704-731.

31. Cotman CW, Berchtold NC, Christie LA. (2007). Exercise builds brain health: key roles of growth factor cascades and inflammation. Trends in Neurosciences, 30(9), 464-472.

32. Boström P, Wu J, Jedrychowski MP, et al. (2012). A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature, 481(7382), 463-468.

33. Moon HY, Becke A, Berron D, et al. (2016). Running-induced systemic cathepsin B secretion is associated with memory function. Cell Metabolism, 24(2), 332-340.

34. van Praag H, Christie BR, Sejnowski TJ, Gage FH. (1999). Running enhances neurogenesis, learning, and long-term potentiation in mice. Proceedings of the National Academy of Sciences USA, 96(23), 13427-13431.

35. van Praag H, Shubert T, Zhao C, Gage FH. (2005). Exercise enhances learning and hippocampal neurogenesis in aged mice. Journal of Neuroscience, 25(38), 8680-8685.

36. Erickson KI, Voss MW, Prakash RS, et al. (2011). Exercise training increases size of hippocampus and improves memory. Proceedings of the National Academy of Sciences USA, 108(7), 3017-3022.

37. Voss MW, Vivar C, Kramer AF, van Praag H. (2013). Bridging animal and human models of exercise-induced brain plasticity. Trends in Cognitive Sciences, 17(10), 525-544.

38. Erickson KI, Hillman C, Stillman CM, et al. (2019). Physical activity, cognition, and brain outcomes: a review of the 2018 physical activity guidelines. Medicine and Science in Sports and Exercise, 51(6), 1242-1251.

39. Colcombe SJ, Kramer AF. (2003). Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychological Science, 14(2), 125-130.

40. Northey JM, Cherbuin N, Pumpa KL, Smee DJ, Rattray B. (2018). Exercise interventions for cognitive function in adults older than 50: a systematic review with meta-analysis. British Journal of Sports Medicine, 52(3), 154-160.

41. Schuch FB, Vancampfort D, Richards J, Rosenbaum S, Ward PB, Stubbs B. (2016). Exercise as a treatment for depression: a meta-analysis adjusting for publication bias. Journal of Psychiatric Research, 77, 42-51.

42. Cooney GM, Dwan K, Greig CA, et al. (2013). Exercise for depression. Cochrane Database of Systematic Reviews, (9), CD004366.

43. Kandola A, Ashdown-Franks G, Hendrikse J, Sabiston CM, Stubbs B. (2019). Physical activity and depression: towards understanding the antidepressant mechanisms of physical activity. Neuroscience & Biobehavioral Reviews, 107, 525-539.

44. Phillips C. (2017). Brain-derived neurotrophic factor, depression, and physical activity: making the neuroplastic connection. Neural Plasticity, 2017, 7260130.

45. Loucks AB, Heath EM. (1994). Dietary restriction reduces luteinizing hormone (LH) pulse frequency during waking hours and increases LH pulse amplitude during sleep in young menstruating women. Journal of Clinical Endocrinology and Metabolism, 78(4), 910-915.

46. Loucks AB. (2003). Energy availability, not body fatness, regulates reproductive function in women. Exercise and Sport Sciences Reviews, 31(3), 144-148.

47. Yeager KK, Agostini R, Nattiv A, Drinkwater B. (1993). The female athlete triad: disordered eating, amenorrhea, osteoporosis. Medicine and Science in Sports and Exercise, 25(7), 775-777.

48. Nattiv A, Loucks AB, Manore MM, et al. (2007). American College of Sports Medicine position stand: The female athlete triad. Medicine and Science in Sports and Exercise, 39(10), 1867-1882.

49. Mountjoy M, Sundgot-Borgen J, Burke L, et al. (2014). The IOC consensus statement: beyond the female athlete triad—Relative Energy Deficiency in Sport (RED-S). British Journal of Sports Medicine, 48(7), 491-497.

50. Mountjoy M, Sundgot-Borgen J, Burke L, et al. (2018). IOC consensus statement on relative energy deficiency in sport (RED-S): 2018 update. British Journal of Sports Medicine, 52(11), 687-697.

51. Williams NI, Leidy HJ, Hill BR, Lieberman JL, Legro RS, De Souza MJ. (2015). Magnitude of daily energy deficit predicts frequency but not severity of menstrual disturbances associated with exercise and caloric restriction. American Journal of Physiology - Endocrinology and Metabolism, 308(1), E29-E39.

52. De Souza MJ, Nattiv A, Joy E, et al. (2014). 2014 Female Athlete Triad Coalition consensus statement on treatment and return to play of the female athlete triad. British Journal of Sports Medicine, 48(4), 289.

53. Nieman DC. (1994). Exercise, infection, and immunity. International Journal of Sports Medicine, 15 Suppl 3, S131-S141.

54. Campbell JP, Turner JE. (2018). Debunking the myth of exercise-induced immune suppression: redefining the impact of exercise on immunological health across the lifespan. Frontiers in Immunology, 9, 648.

55. Meeusen R, Duclos M, Foster C, et al. (2013). Prevention, diagnosis, and treatment of the overtraining syndrome: joint consensus statement of the European College of Sport Science and the American College of Sports Medicine. Medicine and Science in Sports and Exercise, 45(1), 186-205.

56. Schoenfeld BJ, Grgic J, Ogborn D, Krieger JW. (2017). Strength and hypertrophy adaptations between low- vs. high-load resistance training: a systematic review and meta-analysis. Journal of Strength and Conditioning Research, 31(12), 3508-3523.

57. Schoenfeld BJ, Grgic J, Krieger J. (2019). How many times per week should a muscle be trained to maximize muscle hypertrophy? A systematic review and meta-analysis of studies examining the effects of resistance training frequency. Journal of Sports Sciences, 37(11), 1286-1295.

58. Schoenfeld BJ, Aragon AA, Krieger JW. (2013). The effect of protein timing on muscle strength and hypertrophy: a meta-analysis. Journal of the International Society of Sports Nutrition, 10(1), 53.

59. Bhasin S, Storer TW, Berman N, et al. (1996). The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. New England Journal of Medicine, 335(1), 1-7.

60. Pope HG Jr, Wood RI, Rogol A, Nyberg F, Bowers L, Bhasin S. (2014). Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement. Endocrine Reviews, 35(3), 341-375.

61. Phillips SM, Van Loon LJC. (2011). Dietary protein for athletes: from requirements to optimum adaptation. Journal of Sports Sciences, 29 Suppl 1, S29-S38.

62. Morton RW, Murphy KT, McKellar SR, et al. (2018). A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. British Journal of Sports Medicine, 52(6), 376-384.

63. Kreider RB, Kalman DS, Antonio J, et al. (2017). International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. Journal of the International Society of Sports Nutrition, 14, 18.

64. Goldstein ER, Ziegenfuss T, Kalman D, et al. (2010). International society of sports nutrition position stand: caffeine and performance. Journal of the International Society of Sports Nutrition, 7(1), 5.

65. Wernbom M, Augustsson J, Thomeé R. (2007). The influence of frequency, intensity, volume and mode of strength training on whole muscle cross-sectional area in humans. Sports Medicine, 37(3), 225-264.

66. Krieger JW. (2010). Single vs. multiple sets of resistance exercise for muscle hypertrophy: a meta-analysis. Journal of Strength and Conditioning Research, 24(4), 1150-1159.

67. Damas F, Phillips S, Vechin FC, Ugrinowitsch C. (2015). A review of resistance training-induced changes in skeletal muscle protein synthesis and their contribution to hypertrophy. Sports Medicine, 45(6), 801-807.

68. McGlory C, Devries MC, Phillips SM. (2017). Skeletal muscle and resistance exercise training; the role of protein synthesis in recovery and remodeling. Journal of Applied Physiology, 122(3), 541-548.

69. Pelliccia A, Sharma S, Gati S, et al. (2021). 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. European Heart Journal, 42(1), 17-96.

70. Joyner MJ, Lundby C. (2018). Concepts about VO2max and trainability are context dependent. Exercise and Sport Sciences Reviews, 46(3), 138-143.

71. Bassett DR, Howley ET. (2000). Limiting factors for maximum oxygen uptake and determinants of endurance performance. Medicine and Science in Sports and Exercise, 32(1), 70-84.

72. Brooks GA, Mercier J. (1994). Balance of carbohydrate and lipid utilization during exercise: the "crossover" concept. Journal of Applied Physiology, 76(6), 2253-2261.

73. Stillman CM, Cohen J, Lehman ME, Erickson KI. (2016). Mediators of physical activity on neurocognitive function: a review at multiple levels of analysis. Frontiers in Human Neuroscience, 10, 626.

74. Chaddock-Heyman L, Erickson KI, Voss MW, et al. (2013). The effects of physical activity on functional MRI activation associated with cognitive control in children: a randomized controlled intervention. Frontiers in Human Neuroscience, 7, 72.

75. Stillman CM, Esteban-Cornejo I, Brown B, Bender CM, Erickson KI. (2020). Effects of exercise on brain and cognition across age groups and health states. Trends in Neurosciences, 43(7), 533-543.

76. De Souza MJ, Williams NI, Nattiv A, et al. (2014). Misunderstanding the female athlete triad: refuting the IOC consensus statement on relative energy deficiency in sport (RED-S). British Journal of Sports Medicine, 48(20), 1461-1465.

77. Loucks AB, Kiens B, Wright HH. (2011). Energy availability in athletes. Journal of Sports Sciences, 29 Suppl 1, S7-S15.

78. Areta JL, Burke LM, Ross ML, et al. (2013). Timing and distribution of protein ingestion during prolonged recovery from resistance exercise alters myofibrillar protein synthesis. Journal of Physiology, 591(9), 2319-2331.

79. Bauer J, Biolo G, Cederholm T, et al. (2013). Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. Journal of the American Medical Directors Association, 14(8), 542-559.

80. Hawley JA, Burke LM, Phillips SM, Spriet LL. (2011). Nutritional modulation of training-induced skeletal muscle adaptations. Journal of Applied Physiology, 110(3), 834-845.

81. Fearon K, Strasser F, Anker SD, et al. (2011). Definition and classification of cancer cachexia: an international consensus. Lancet Oncology, 12(5), 489-495.

82. Phillips SM. (2014). A brief review of critical processes in exercise-induced muscular hypertrophy. Sports Medicine, 44 Suppl 1, S71-S77.